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-SUMMARY
Events occurring at the gastrointestinal mucosa have 
implications for the absorption of nutrients and the 
protection of the surface epithelium. In recent years, 
accumulating evidence suggests that the mucosal surface pH 
can differ from that of the bulk perfusing solution and 
that the surface pH is not necessarily the same in 
different areas of the alimentary tract. Measurements of 
surface pH have been performed by previous workers in 
animals both In vitro and in vivo and in human biopsy 
material. However, a comprehensive characterisation of 
gastro-duodenal mucosal surface pH in humans in vivo has 
yet to be published and no information exists at all about 
human in vivo jejunal mucosal pH. The purpose of this 
investigation was to measure gastrointestinal mucosal pH in 
humans in vivo and to compare results obtained from control 
patients and patients with gastrointestinal disease.
Existing measuring systems of gastrointestinal pH are 
specifically designed to measure luminal pH or are 
unsuitable for mucosal pH measurements. Consequently, to 
measure mucosal pH in humans in vivo* two novel measuring 
systems were employed. To measure gastro-duodenal mucosal 
pH, an electrode was passed through the biopsy channel of 
an endoscope. Using this technique, the electrode could be 
seen to touch the mucosa in specifiable areas when 
measurements were made at endoscopy. Proximal intestinal 
mucosal pH was measured by attaching a plastic pH electrode 
to a Crosby biopsy capsule. When swallowed, the capsule- 
electrode assembly allowed for continuous measurement of
(xiii)
intestinal mucosal pH and the retrieval of biopsy material 
for histological and biochemical analysis. A plastic pH 
electrode was required for use at jejunal biopsy because of 
the unsuitability of available glass electrodes. Two 
hydrogen ion-selective carriers were compared for their 
suitability as components in a plastic electrode for use in 
humans. The plastic pH electrodes were developed and 
constructed in the laboratory and the electrode properties 
were extensively characterised. The electrodes used at 
jejunal biopsy had comparable operational characteristics 
to glass pH electrodes within the physiological pH range.
Measurements of jejunal mucosal pH were obtained in 9 
control, 13 coeliac and 11 irritable bowel syndrome (IBS) 
patients. A pH gradient ranging from near neutral in the 
duodenum to an acidic pH of 5.9 in the jejunum was measured 
in control patients. In contrast, coeliac patients had a 
significantly alkaline pH in the duodenum and a jejunal 
mucosal pH of 6.7, significantly less acid than control 
values. Coeliac patients on a normal diet had a near neutral 
mucosal pH while that of patients on a gluten free diet was 
still significantly elevated. In IBS patients, jejunal 
mucosal pH was not significantly different from control 
values. An elevated jejunal mucosal pH in coeliac disease 
may result from a loss of acid secreting villous tip cells 
and neutral or alkaline secretion from the increased numbers 
of crypt cells associated with coeliac disease. There may 
also be a contribution from increased tissue permeability.
Measurements of gastro-duodenal mucosal pH revealed 
that acid in the stomach had a significant influence on the
(xiv)
recorded pH. Without gastric acid (pH>3), the mucosal pH 
was close to neutrality from the fundus to the duodenum in 
control patients. In contrast, in the presence of acid 
(pH<3), fundal and antral mucosal pHs were significantly 
more acidic than neutral. Duodenal pH was unaffected by the 
presence of acid in the stomach. In patients with gastric 
ulcer, the antral surface pH was near neutral in the 
absence of gastric acid and remained elevated even when 
acid was present. In gastric ulcer, a more alkaline antral 
surface pH was also associated with active ulceration but 
less so with healing ulcers and with gastritis without 
ulceration. Similarly, duodenal ulcer was associated with a 
strikingly alkaline duodenal mucosal pH. Once again, acid 
in the stomach accentuated the elevation in duodenal 
mucosal pH when compared with control values.
It is proposed in the cytoprotection hypothesis that 
the mucosa can maintain a neutral surface pH in the 
presence of acid and that peptic ulcer patients have a 
reduced capacity to maintain this neutral layer. From the 
results obtained in this project, it is proposed that it is 
normal for acid to dissipate the "mucus-bicarbonate" layer 
and reduce mucosal pH. In addition, peptic ulceration is 
associated with alkalinity in the affected area and not a 
reduced mucosal pH as predicted. An hypothesis is presented 
which suggests that this alkalinity is inappropriate and 
may have pathological consequences for subsequent control 
of acid secretion, gastric emptying and pancreatic 
bicarbonate secretion.
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PREFACE
The main objective of this project was to measure the 
pH at the mucosal surface of the human stomach and proximal 
small intestine in .yiys. The reasoning behind this 
objective originates from recently revived interest in 
mucosal events associated with gastrointestinal diseases. 
Measurements of mucosal surface pH may lead to a better 
understanding of how diseases affect the mucosal tissue. 
Maintenance of the pH of the mucosal surface has 
implications for absorption of dissociable weak- 
electrolytes and for the protection of the stomach and 
duodenum. Alterations in surface pH would therefore disrupt 
the normal functions of the mucosa.
However, the majority of devices used for gastro­
intestinal pH measurements are inadequate for measuring 
mucosal surface pH. Through necessity therefore, some of 
the project was devoted to developing suitable systems for 
measuring in vivo mucosal surface pH during routine 
clinical investigations. For this reason, the format of 
this thesis is rather unconventional. The format is 
intended to lead the reader through each separate stage of 
the project so that a clear picture of the overall task is 
gradually created. This is hopefully achieved by initially 
describing the clinical relevance of the work, followed by 
an analysis of why existing measuring systems cannot 
adequately fulfill the requirement of measuring mucosal 
surface pH. This progresses into a detailed section on 
plastic pH electrodes which are necessary components of one
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of the devised measuring systems to be used. It is after 
this stage that the clinical experimental work, in which 
mucosal surface pH is measured, is described and the 
findings from these studies are detailed in a clinical 
results section. Finally, the suitability of the selected 
measuring systems is discussed and the findings from the pH 
measurements are put into perspective with particular 
reference to the physiology of the gastrointestinal tract 
and to what extent mucosal events can be altered and 
possibly participate in gastrointestinal disease.
Although an attempt has been made to separate develop­
mental and experimental work, some overlapping of these 
aspects is unavoidable? the reader"s forbearance would be 
appreciated during such instances.
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INTRODUCTION
1 i) The Clinical Context
The gastrointestinal mucosa is lined with mucus which, 
as well as acting as a lubricant, is thought to be a 
protective layer against tissue damaging substances. 
Accumulating evidence suggests that this mucus layer can 
have a different pH to that of the gastrointestinal bulk 
contents and that the surface pH is not necessarily the 
same in different areas of the alimentary tract. It is not 
known what happens to the pH of this mucus layer when 
disease affects the mucosa. Peptic ulceration and coeliac 
disease are two instances where knowledge of the mucosal 
surface pH may be an important factor in understanding what 
happens to the tissue during gastrointestinal disease. It 
is perhaps appropriate to examine the evidence which 
suggests that the surface pH might be of importance in 
peptic ulceration and coeliac disease.
i a) Peptic ulcer disease and gastric ac.i*L-
The search for the cause of peptic ulceration has 
centred on two major questions: a) is there a change in the 
aggressive factors thought to be responsible for ulceration 
and b) do the defence mechanisms responsible for protecting 
the mucosa alter in any way which may allow ulceration to 
occur? These are not necessarily exclusive mechanisms. The 
relationship of acid to ulceration has proved to be easier 
to investigate than the link between mucosal defence 
mechanisms and ulceration. This is only because 
technological developments have not kept pace with
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advancing scientific ideas. What follows is a brief 
introduction to some of the ideas concerned with gastric 
acid which have been suggested as aetiological factors in 
the development of ulceration.
If a patient with peptic ulcer disease was asked what 
he thought was the possible cause of his condition, his 
answer may well be that he was secreting too much acid. 
However, when measurements of basal (1) and stimulated 
maximal (2) acid secretion from control and peptic ulcer 
patients were compared, there was considerable overlap 
between groups. In cases of gastric ulcer, acid secretion 
is often similar to or lower than normal (2,3,4,5,6) . Acid 
secretion decreases with age (2,3) and this, associated 
with the increase in incidence of gastric ulcer with age 
(2), may possibly explain the lower levels of acid 
recovered in some gastric ulcer patients. Only one third of 
duodenal ulcer patients have acid hypersecretion 
(2,3,4,5,6) and whether or not duodenal ulcer patients with 
high acid output had such high levels before ulceration 
occurred is uncertain. Evidence (2,7) suggests that when 
the ulcer first develops, the acid secretion is normal but 
increases as the disease progresses. Therefore an increased 
level of acid secretion is unlikely to be a prerequisite 
for mucosal damage although it is accepted that acid must 
be present at some stage, since patients with pernicious 
anaemia never develop peptic ulceration. While suppression 
of acid secretion is an effective clinical treatment for 
ulceration, this does not answer the more physiological 
question of whether excess acid prior to ulceration is
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instrumental in causing the ulceration. In short, there is 
no clear picture of acid secretory capacity before, during 
or after gastric and duodenal mucosal ulceration.
As well as studies of acid secretion, there have been 
investigations of the acid neutralising capabilities of the 
stomach and small intestine. The idea that the persistence 
of peptic ulcer was due to an imbalance between gastric 
acid and the alkaline secretions of the duodenum was 
proposed in 1929 (8). This suggestion encouraged others to 
compare gastric and duodenal secretions, initially by 
aspirating fluid samples (9,10) and latterly by measurement 
with glass pH electrodes (11,12,13,14,15,16,17,18,19,20, 
21) .
The reports stemming from this type of study are not 
consistent in experimental technique and there are many 
conflicting results. There are discrepancies about the 
relationship between acid secretory capacity and duodenal 
pH. In one study (9) no parallel relationship between 
acidity in the duodenal bulb and any of the customary 
indices of gastric acidity could be found. However, a 
positive correlation between peak acid output and log mean 
hydrogen ion activity in the proximal duodenum has been 
observed in more recent studies (20).
A similarly inconclusive situation exists concerning 
duodenal bulb pH and neutralising ability. Some 
investigators suggested that the first portion of the 
duodenum is more acid for longer periods of time in 
duodenal ulcer patients (9,22,23). In contrast, no
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differences in duodenal bulb acidity have been found by 
later workers (16,17,23). Although finding no significant 
differences in duodenal mean pH between patient groups, 
McCloy (21) did notice that there were significantly longer 
periods of acidification of the duodenal bulb in ulcer 
patients.
The technically difficult task of maintaining 
electrodes or aspiration tubes in the duodenal bulb is a 
major obstacle to obtaining reproducible results. It is not 
too difficult to maintain measuring devices at fixed 
positions within more distal regions of the duodenum. The 
pH in the distal duodenum is more stable than that in the 
duodenal bulb. However, this is not the area where duodenal 
ulcers frequently occur. Correspondingly, there is a 
greater consensus of results which indicates that there is 
no difference in pH between control and duodenal ulcer 
patients (13 ,17 ,24 ,25). This does not imply that a 
difference does not exist in the bulb, only that 
neutralisation is complete in the distal part of the 
duodenum.
Measurements of duodenal bulb pH have not conclusively 
indicated whether or not there is an imbalance between 
gastric acid and duodenal alkalinity in duodenal ulcer 
disease. If there is an excess of acid entering the 
duodenum, it must be derived from increased acid secretion, 
an increased rate of gastric emptying, or a combination of 
the two. Considering that few patients with duodenal ulcer
hypersecretors of gastric acid, the possibility of the 
duodenum receiving acid at more frequent intervals may be a
more reasonable hypothesis. Compared to control patients, 
duodenal ulcer patients have an increased rate of gastric 
emptying (26,27), although this was not shown in earlier 
studies (28,29). An increased rate of gastric emptying 
could account for the longer and more frequent periods of 
acidity measured in duodenal ulcer patients (9,21,22).
An increase in the acidity of the duodenal bulb caused 
by an increased rate of gastric emptying is not what would 
be predicted from studies on the control of gastric 
emptying. Sufficient evidence exists to suggest that acid 
in the duodenum inhibits gastric emptying (4,30) and acid 
secretion (4,31). In dogs, the receptors mediating this 
inhibitory effect are in the first 5cm of the duodenum 
(32,33), although to-date, no anatomical evidence for their 
existence has been found. The inhibitory pathways may be 
neural (34,35,36,37,38,39), humoral (40,41) or both. The 
inhibition of gastric secretion may be mediated by secretin 
(41) released from the duodenum in response to acid 
impinging on the mucosa. If secretin regulates gastric 
emptying, the lower level of secretin release detected in 
duodenal ulcer patients (42) would perhaps explain the 
increased rate of gastric emptying in ulcer patients. Just 
why duodenal ulcer patients should have lower levels of 
secretin release has not yet been explained. We are left 
with the conclusion that while much work has been done with 
respect to gastric acid and peptic ulceration, little is 
still known about how these two aspects are related.
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Secretin is also thought to be the humoral agent 
responsible for the control of bicarbonate secretion from 
Brunner's glands in the duodenum (43,44) and the secretion 
of bicarbonate from the pancreas (4,45). Consequently, 
secretin may not only control the duodenal environment by 
inhibiting acid secretion and gastric emptying but also by 
stimulating the mechanisms responsible for protecting the 
mucosa.
i b) Peptic ulceration and mucosal defence-
Mucosal defence against gastric acid relies on the acid 
being neutralised by bicarbonate. Bicarbonate is derived 
from pancreatic and biliary secretions into the duodenum 
and from mucosal secretions in the duodenum (46,47) and 
stomach (48,49,50,51). Measurements of pancreatic 
bicarbonate and gastric acidity output have once again 
produced conflicting results. It is agreed that bicarbonate 
secretion from the pancreas is more than adequate to 
neutralise acid output in control patients (52,53). 
In duodenal ulcer patients it is suggested (52) that 13 out 
of 15 subjects studied could neutralise peak gastric acid 
output. In contrast, others (53) have stated that although 
pancreatic output was normal in ulcer patients, maximal 
gastric acid was higher than in control patients. In a 
subsequent paper (54) it has been shown that even if 
bicarbonate secretion equals the amount of acid in the 
duodenum, this does not necessarily imply that 
neutralisation will be complete. In fact, neutralisation 
will depend on the concentration of acid and bicarbonate 
and on the partial pressure of C02 in the duodenum. Unless
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all these factors are known, the value of this type of 
study is diminished.
The idea of the mucosa having its own protection 
against acid has been suggested repeatedly in the past 
(46,55,56) but it has only been in the last decade that the 
mechanism behind this protection has been studied in a 
concerted way. A "mucus-bicarbonate" barrier (50,57,58) 
which buffers intraluminal acid by maintaining a neutral pH 
at the mucosal surface is currently thought to be the means 
by which the mucosa prevents itself from being digested. 
Studies on frog gastric fundic mucosa in vitro (48) 
suggested that there was a low basal secretion of 
bicarbonate from the tissue. The guinea pig is also capable 
of producing basal gastric bicarbonate in vivo (49). The 
amphibian duodenum, in yiii-Qr apparently secretes 
bicarbonate which has both an active and a passive 
component (59,60). It would appear that duodenal 
bicarbonate secretion is not restricted to amphibians for 
it has also been measured in vivo in rats, guinea pigs, 
cats, rabbits, dogs, pigs (61) and humans (62).
Microelectrode studies of gastric mucosal surface pH 
reveal that there is a gradient of increasing pH from the 
bathing medium to the tissue surface in rabbits in vitro 
(63) , rats in vivo (6 4) and humans in vitCQ. (6 5). The human 
studies are difficult to interpret because abnormal 
specimens were studied from patients given anti-motility 
and anti-secretory drugs. A similar pH gradient has been 
measured in rat duodenal tissue Aa x±ya (66). 
Interestingly, the fact that the local duodenal mucosal pH
need not reflect luminal pH in dogs was reported as long 
ago as 1965 (67). More recently it has been shown in humans 
that patients secreting acid have a neutral duodenal mucosa
(68) which remains so even when bathed with exogenous acid
(69) .
If a "mucus-bicarbonate" barrier exists in humans, an 
imbalance between mucosal protection factors and acid and 
pepsin impinging on the mucosa could result in mucosal 
damage (46). Ethanol, anti-inflammatory drugs and bile 
salts are well recognised initiators of mucosal damage 
(4,57,58). Their mode of action could be through breaking 
down the mucus lining of the mucosa and allowing acid and 
pepsin to attack the tissue. Such damage tends to be 
diffuse in nature and does not explain the localisation of 
peptic ulcers in certain common areas. Despite present 
knowledge of the mucosal protective system it is apparent 
that the mechanisms behind the initiation of a peptic ulcer 
are not fully understood.
On the assumption that an imbalance may exist between 
aggressive and protective mechanisms an obvious experiment 
is to measure the pH of the mucosa in normal and 
pathological conditions. If the pH at the surface of the 
tissue is less in ulcer patients than control patients, 
this would provide crucial evidence that an acid-alkali 
imbalance is present in peptic ulceration. To-date there 
have only been two studies (70,71) of gastric and duodenal 
mucosal pH in humans in relatively undisturbed conditions. 
In neither study could differences in mucosal pH be found
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between normal and duodenal ulcer patients, although 
changes in gastric pH were noted in gastric ulcer and 
gastritis patients. It was for this reason that this 
project was undertaken to measure gastric and duodenal 
mucosal pH with the hope that a better understanding of 
mucosal defence mechanisms would emerge.
i c) Small intestinal disease and mucosal pH,
The second aim of the study was to look at how diseases 
of the small intestine affect mucosal surface pH in situ. 
When anastomosed to the stomach, the jejunum is highly 
susceptible to ulceration (72). The conclusion drawn from 
this observation is that, unlike the duodenum, the jejunum 
lacks adequate protection against gastric acid. Although 
ulceration of the jejunum is a rare occurrence in patients 
without a gastro-jejunostomy, it is still possible that 
diseases affecting the jejunal mucosa may alter the mucosal 
surface pH. Indeed, the in vitro pH of human jejunal tissue 
(73,74) is more alkaline in patients with coeliac disease 
than the surface mucosal pH of control patients. Coeliac 
disease is associated with changes in jejunal mucosal 
structure and absorptive function.
An altered jejunal surface pH, were this to be found in 
yivo, would help to explain certain clinical abnormalities 
associated with coeliac disease. Such abnormalities are 
typified by the following examples. The presence of 
steatorrhoea is a prime indication that a patient may have 
coeliac disease. The failure to absorb fatty acids, leading 
to steatorrhoea, may be the result of an abnormal mucosal 
surface pH. A precedent to this proposal is that fatty acid
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absorption increases with decreasing luminal pH (75). 
Depending on the pKa of the fatty acid, the pH at the 
mucosal surface will determine the extent of dissociation. 
With non-ionic diffusion, absorption across a lipid 
membrane is enhanced when the compound is in the un­
ionised, or neutral, form (76,77,78). Hence, if a change in 
surface pH shifts the dissociation equilibrium of a fatty 
acid to the ionised species, the rate of absorption will be 
reduced and steatorrhoea will follow.
In accordance with the pH-partition theory of non-ionic 
diffusion described above, changes in mucosal surface pH 
would also explain folate malabsorption in coeliac disease 
(79). In a similar fashion to fatty acid absorption, folate 
absorption is highly pH dependent (80,81). Much of the 
initial in vitro work on jejunal surface pH (73,7 4,81,82) 
was done with reference to its influence on folate 
malabsorption.
Subsequently the idea of surface pH affecting the 
absorption of other compounds has been expanded to the 
field of weak-electrolytes taken in the form of drugs for 
the treatment of diseases unrelated to the digestive tract. 
The paradoxical reversal of rates of absorption of weak 
acids and bases in coeliac disease, compared to control 
patients (83,84,85), can also be attributed to the state of 
ionisation of the drug. The increased surface pH of coeliac 
tissue in vitro (73,74) suggests that weak bases will be 
preferentially absorbed while the absorption of weak acids
will be reduced.
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The measurement of surface pH in patients with coeliac 
disease and in control patients in vivo would show if in 
vitro observations (73,74) accurately reflect coeliac 
jejunum in situ. However, there have been very few in vivo 
studies of the pH of the distal duodenum and proximal 
jejunum in humans and such information as is available 
exclusively relates to luminal pH (18,80,86,87,88,89). For 
this reason, in vivo measurements of jejunal surface pH 
were made in patients with functional intestinal disorders.
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1 ii) Existing PH Measuring Systems
So far, the clinical relevance of mucosal surface pH 
has been outlined. To test the idea that mucosal surface pH 
is altered in human gastrointestinal disease it is 
necessary to make in vivo measurements. However, an 
assessment of available measuring systems suggested none 
were suitable for the proposed study. To illustrate this 
point, what follows is an appraisal of these unsatisfactory 
options. It is not the intention of this introduction to 
review the numerous studies of gastrointestinal pH that 
have been published over the last hundred years or more. 
The history and development of gastric analysis prior to 
1939 is outlined in an excellent review by Hollander and 
Penner (90,91,92) to which the interested reader is 
referred. The following review will therefore confine 
itself to technical developments in the last forty five 
years.
The use of oral or nasal intubation with aspiration of 
gastrointestinal content is a simple, prevalent method for 
examining gastric or intestinal secretions. Fluid 
aspiration has several disadvantages, the main one being 
that the pH of aspirated fluid reflects the situation 
prevailing in the lumen and does not allow inferences to be 
made about the mucosal surface pH. Aspirates can be 
mixtures of fluid of uncertain origin or from a specific 
region but with an unspecifiable degree of contamination 
from other areas. Continual removal of fluid may itself 
have an effect on subsequent secretions and this could be
misleading.
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An alternative which circumvents fluid removal is to 
place a dialysis bag containing distilled water in the 
stomach (93). Hydrogen ions then diffuse from the gastric 
secretion into the bag and dialysate hydrogen ion 
concentration is measured by titration after recovery from 
the stomach. A more complex system based on the same 
principle is the use of ion exchange resins (94). Resin, 
containing the dye azure A, will exchange molecules of the 
dye for hydrogen ions when they react with the resin. The 
azure A is absorbed into the blood and the amount of dye 
appearing in the urine is proportional to the amount of 
hydrogen ion in the gastric secretion. However, both of the 
above methods of measuring gastrointestinal pH again only 
provide a measure of the concentration of acid in the 
lumen.
In the methods described above, measurements of pH are 
made either at intermittent time intervals or only at the 
end of the experimental period. Continuous assessment of In 
situ pH is not possible with these systems. Consequently, 
any transient fluctuations in hydrogen ion secretion 
between the selected sampling intervals will not be 
recorded. In contrast, In situ glass pH electrodes provide 
fast, reliable and continuous recordings of gastro 
intestinal pH. The In si-til electrode system has been used 
in many forms with varying degrees of success. 
Miniaturisation of the electrode and electrode recording 
equipment has been the most notable development in recent 
times. This has led to increasing patient tolerance of the 
system during investigative procedures. Apart from the
15
conventional glass pH electrode attached to a conducting 
cable, electrodes based on the principle of radiotelemetry 
have also been used for gastrointestinal pH measurements 
(95,96,97). Unlike conventional glass electrodes, the use 
of radiotelemetry devices has not found favour amoung 
research workers because they usually require lengthy pre­
conditioning before use and are often unreliable.
Studies of in niiii gastrointestinal pH using pH 
electrodes have been limited to the measurement of luminal 
content pH. Electrodes floating free in the lumen of the 
stomach or intestine may make contact with the mucosa at 
some stage, a fact recognised and prevented by past 
investigators (11,18,67). Even if the electrode does make 
contact with the mucosa the frequency and duration of 
contact is impossible to determine. The shape of the pH 
sensitive glass bulb will almost inevitably ensure that 
some contribution to the recorded value will come from the 
lumen. Thus, the recorded pH will be a composite of mucosal 
and luminal fluid pH. Finally, a further disadvantage of 
free floating electrodes is the problem associated with 
maintaining the electrode within the area of interest. The 
use of electrode, combinations (16,17,19,20,98), although 
partially successful in determining the location of an 
electrode, are cumbersome and not particularly reliable.
From this brief discussion, it must be concluded that 
existing methods of measuring gastrointestinal pH are not 
suited for the measurement of mucosal surface pH In yivn. 
For the measurement of gastric and proximal duodenal 
mucosal pH a system where a pH electrode is taped to the
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outside of an endoscope has recently been developed (Lucas 
& Holmes 1977, personal communication & ref 70). 
Development of miniaturised electrodes allowed passage of 
an electrode through the biopsy channel of the endoscope 
(71). The combination of fibre-optic flexible endoscopes 
and miniaturised pH electrodes is undoubtedly a useful 
development. This has finally allowed mucosal surface pH to 
be measured conveniently and with precision in specifiable 
areas. It has opened up new possibilities for investigating 
In situ mucosal conditions which, until now, have only been 
studied in vitro or have been implied from animal models.
The endoscope can only reach as far as the second part 
of the duodenum without causing severe discomfort. For this 
reason another means of delivering an electrode to the 
small intestinal mucosa was required. This was found in the 
form of an electrode attached to a Crosby biopsy capsule. 
With an electrode appropriately positioned, contact between 
the pH sensitive tip and the mucosa could be virtually 
ensured. The inflexibility and rounded pH sensitive tip of 
conventional glass electrodes made them unsuitable for use 
with the Crosby biopsy capsule system. A plastic, flexible 
electrode was a possible solution to these restrictions. 
However, plastic pH electrodes are not commercially 
available and therefore these had to be produced within the 
laboratory.
In summary, in order to make mucosal pH measurements In 
situ, two new measuring systems were required. While the 
endoscopy procedure for measuring mucosal surface pH has
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previously been described, the Crosby biopsy capsule and 
electrode combination was an untested but potentially 
useful device for measuring small intestinal mucosal pH. 
Before describing these techniques in more detail, an 
account of the construction and characteristics of plastic 
pH electrodes, which were eventually used at jejunal 
biopsy, must first be presented.
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PLASTIC £H ELECTRODES
2 i) Introduction
Although there is an extensive literature on ion- 
selective electrodes, most of the reported work has been 
orientated to the theoretical aspects and the application 
of these electrodes to analytical chemistry. Less 
frequently encountered in the literature are designs for 
electrodes suitable for clinical investigations. Some 
efforts have been made at applying electrode technology to 
biological and clinical problems, particularly in the areas 
of hydrogen (99,100,101), potassium (102,103), calcium 
(104), sodium (105) and methadone (106) ion determinations. 
All these electrodes have been successful for their 
particular purposes but none were refined enough for 
clinical applications, particularly for in situ work on 
humans. Such an electrode has to be robust, preferably re­
usable, and safe for use in clinical experiments. It was 
the aim of this project to develop a pH electrode to these 
specifications. Prior to describing the construction of 
plastic pH electrodes it will be necessary to review 
briefly some theoretical aspects of ion-selective 
electrodes with particular emphasis on pH electrodes.
A pH electrode is an electrochemical concentration cell 
comprising two metal electrodes immersed in two solutions, 
each with a different activity of hydrogen ions. These 
solutions are separated from each other by a semi permeable 
membrane which selectively allows hydrogen ions to pass 
through. As hydrogen ions move down their activity
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gradient, an electrical gradient opposes the movement of 
the ions. The total potential energy difference across the 
membrane is called the electrochemical potential difference 
(u). u is the sum of the electrical and concentration 
potential energy differences across the membrane.
That is u=We+Wc 
where W e is the electrical potential energy difference and 
W c is the chemical potential energy difference.
When W e=wc, then hydrogen ions will be in equilibrium 
across the membrane and u will be zero.
W e is the product of EH, the transmembrane voltage due to 
H+ ions, F, the Faraday constant and nH, the valency of 
hydrogen ions.
That is We=nHFEH
W c is proportional to the difference between the natural 
logarithms of the internal and external hydrogen ion 
activities.
That is Wc= RT1 nJ^ AHJ_^
o
where R is the universal gas constant, T is absolute 
temperature and [AR]± and [AH]Q are the activities of 
hydrogen ions on either side of the membrane.
Therefore, the electrochemical potential difference is
described by the equation:
u=nHFEH + RTln[AH ] i 
(aH]o
At equilibrium, u=0 and the equation can be rewritten as:
E„=RT ln[AHli 
^  [AH]0
This is the Nernst equation. Since the membrane potential
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depends on the activity gradient across the membrane, 
changes in the activity of hydrogen ion on one side of the 
membrane will cause the electromotive force of the 
concentration cell to change. Hence, by noting the 
relationship between changes in external hydrogen ion 
activity and changes in potential difference of the cell, a 
means of measuring the activity of hydrogen ions in a test 
solution is made possible.
In highly dilute solutions, the number of hydrogen ions 
that determine the properties of the solution (ie. 
activity) is equal to the number of hydrogen ions added 
(ie. concentration). However, as the solution becomes less 
dilute, the activity of hydrogen ions becomes proportional 
to the concentration. It is thought that the reason for 
this is because a hydrogen ion will attract a cloud of 
negatively charged particles and will repel other hydrogen 
ions. This attraction of unlike charges and repulsion of 
like charges applies to all ions in solution. Hence, the 
ions in solution become ordered and this order opposes the 
natural tendency for the entropy of the system to reach a 
maximum, that is, to become disordered because of the 
thermal energy in the system. Consequently there are fewer 
"active" hydrogen ions in solution as the concentration 
increases. An empirical relationship between the 
concentration of ions and their activity has been described 
by the Debye-Huckel equation which can be found in most 
texts on electrochemistry and will therefore not be 
described here.
21
In most practical circumstances, biological solutions 
are not highly dilute and the electrode membrane potential 
will be determined not by the concentration of hydrogen 
ions in the solution but by their activity. Consequently, 
calibration of pH electrodes should be performed using 
buffers of known hydrogen ion activity prior to measuring 
the pH of a test solution.
For a univalent ion such as hydrogen, a ten fold change 
in hydrogen ion activity represents an electrode potential 
change of 58mV at 20°C. Therefore, an "ideal" plastic pH 
electrode would have to have what is referred to as a 
Nernstian response ie. 58mV/pH unit change. However, most 
pH electrodes are not "ideal" since the recorded electrode 
potential is determined not only by the activity of 
hydrogen ions in solution but also by other, interfering 
ions in the same solution. To take into account these 
interfering ions the Nernst equation can be rewritten in a 
form sometimes referred to as the Nicolsky equation:
E tt=RT I n { [ A flj + [ K jjj (A-;) ^ H ^ ^ J ] + • • • }
nflF {Ta h ] }
Here, all the terms are as before except:
kHJ is the selectivity coefficient of an 
interfering ion, J, relative to the sensed ion, H. 
This equation can be extended to allow for all the 
activities of the interfering ions in the solution under 
examination. The degree to which an electrode is affected 
by the activities of interfering ions is a function of the 
ion specificity of the electrode.
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For 1 iguid—membrane electrodes, ion specificity is 
determined by the carrier incorporated in the lipophilic 
solvent which makes up the ion-selective membrane. Carriers 
are either charged or neutral compounds which have an 
affinity for the ion under investigation but must be 
sufficiently hydrophobic to be retained in a lipid or 
lipophilic support membrane. Carriers within liquid- 
membranes function by forming a complex with the selected 
ion which then diffuses through the membrane (107). In 
contrast, the mechanism underlying ion-selective glass 
electrode sensitivity (107), although not fully understood, 
is thought to involve ion exchange at the membrane 
interfaces coupled with movement of cations in a lattice of 
fixed anion sites within the membrane.
Carriers selective for hydrogen ions have been isolated 
from naturally occurring sources. Certain organic weak 
acids, capable of uncoupling oxidative phosphorylation in 
mitochondria, can also increase hydrogen ion permeation 
through lipid bilayers (108). Another naturally occurring 
substance, the 3-hydroxy picolinamide residue of the 
antibiotic virginamycin-S (109) is a proton ionophore.
Many of these naturally occurring proton carriers are 
hydrophilic and are not suitable for incorporation into a 
lipid based membrane. However, larger molecular weight 
homologues of these compounds exhibit both an affinity for 
hydrogen ions and are hydrophobic. One of these, p—octa— 
decyloxy-m-chlorophenylhydrazone-mesoxalonitr ile (OCPH), a 
derivative of a naturally occurring weak acid, functions 
particularly well when incorporated in a solvent polymer
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(99). Similarly, the octylpicolinamide homologue of the 
virginamycin-S proton ionophore, in the solvent o-nitro- 
phenyl octyl ether, can be used in pH sensitive micro- 
electrodes (109).
These two carriers are examples of charged ionophores. 
The activities of monovalent cations, other than the 
hydrogen ions under investigation, can create substantial 
interference when charged ionophores are incorporated into 
electrodes (110). Since organic solvents used for liquid 
membranes also exhibit selectivity for large , but not 
small, ions, discrimination over interfering ions can only 
be achieved if the solvent and carrier have similar ion 
specificity. A low selectivity due to incompatible ion 
specificities of solvent and carrier will result in a 
further reduction of the selectivity if the electrode is 
used in solutions in which the activities of interfering 
monovalent cations is high.
Extremely high selectivities can be achieved by using 
neutral ion-specific carriers as membrane components
(107.110). Neutral carriers are composed of polar and non­
polar groups and assume a stable conformation that provides 
a cavity specific for the uptake of the selected ion
(110.111). The cavity is created by a rigid arrangement of 
the polar groups which have a series of coordination sites, 
while the non-polar groups form a lipophilic shell around 
the coordination centre.
Neutral lipophilic tertiary amines exhibit hydrogen ion 
carrier properties when incorporated in an organic solvent.
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Hydrogen ion neutral-carrier macro (112) and micro (113) 
electrodes, based on tri-n-dodecylamine (TDDA), have 
selectivities almost equal to those of glass pH electrodes. 
By impregnating PVC with carrier containing solvent, 
electrodes with plastic membranes have been constructed 
(112). These plastic membranes were mounted in commercially 
available electrode "bodies" with comparatively large 
surface areas (25mm^). Consequently, these electrodes would 
not be suitable for the proposed clinical investigations 
and it was necessary therefore to develop a new technique 
for constructing electrodes with TDDA incorporated in 
plastic.
Two proton ionophores were selected for use in plastic 
pH prototype electrodes in this study. OCPH, a charged weak 
acid, has been compared with the neutral carrier, TDDA. 
Each compound has been assessed as a suitable candidate for 
the pH electrodes. In particular, their selectivity for 
hydrogen ions over other monovalent cations was examined. 
The performance of the carriers was compared with that of 
glass pH electrodes which, for this study, have been used 
as the standard to which all comparisons are referred. 
Before detailing the results of these comparisons, the 
construction of the plastic electrodes both for laboratory 
and clinical use will be described.
2 ii) Source ot chemicals
The ion selective carrier p-octyldecyloxy-m-chloro 
p h e n y l hydrazone-mesoxalonitrile (OCPH) and the copolymer 
matrix were gifts from Dr. O.H. LeBlanc? GEC, Schenectady,
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N.Y. USA. Tri-n-dodecylamine (TDDA) was purchased from BDH 
Chemicals Ltd., Poole, Dorset, England, as was 
tetrahydrofuran. Dichloromethane, tetraphenylborate and o- 
nitrophenyloctylether were obtained from Fluorochem Ltd., 
Glossop, Derbyshire, England. All PVC tubing used was from 
Portex, Hythe, Kent, England.
For the buffer solutions, citric acid, sodium 
bicarbonate and commercial phthalate buffers were from BDH 
Chemicals Ltd. Potassium hydrogen phthalate came from 
Riedel-de Haen Ag, Seelze-Hannover and Trizma base from 
Sigma Chemical Co., Poole, Dorset, England. Potassium 
dihydrogen orthophosphate and monopotassium phosphate were 
p u r c h a s e d  from Koch-Light L a b o r a t o r i e s  Ltd., 
Buckinghamshire, England.
2 iii) Construction ot plastic electrodes
For the construction of plastic pH electrodes, a 
solution of the appropriate hydrogen ion carrier and its 
corresponding membrane was prepared and stored in liquid 
form. Plastic membrane solutions based on the OCPH carrier 
were prepared by incorporating 1% w/w OCPH in a copolymer 
matrix previously described by Leblanc et al (99). This 
mixture was dissolved in excess dichloromethane. Tri-n- 
dodecylamine (TDDA) membrane solutions were similarly 
prepared. The ion-selective mixture consisted of 30 micro­
litres of the ion-selective carrier, TDDA, dissolved in 200 
microlitres of o-nitrophenyloctylether (o-NPOE), a 
lipophilic solvent through which the carrier could diffuse. 
To this was added 1.2mg sodium tetraphenylborate (NaTPB) 
which created fixed anionic sites within the membrane.
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Fixed anionic sites reduce interference from anions in the 
solution under investigation (114) and therefore increase 
the ion-selectivity of the electrode. The ion-selective 
TDDA mixture was added to lOOmg PVC dissolved in excess 
tetrahydrofuran. Fragments of PVC tubing or powdered PVC 
(Lonzavyl S-704)) could be used. To obtain flexible 
membranes with powdered PVC, 30 microlitres of dibutyl- 
sebacate plasticiser were included in the membrane mixture. 
Solidification of the membrane mixture and prolonged 
storage had no apparent effect, since sensitivity to 
hydrogen ions was detected at least one year later, on 
resuspension of the mixture in fresh solvent.
The same method of casting the hydrogen ion-selective 
membranes was used for both ion exchangers. Sufficient 
solvent was allowed to evaporate until a mixture remained 
which was close to congealing. The end of a length of PVC 
tubing, 1.6mm outside diameter, was dipped in this solution 
and slowly withdrawn (105). A meniscus was formed over the 
end of the tubing which, on evaporation of the solvent, 
left a tough but flexible membrane. Repeated dipping of the 
electrode in the plastic mixture formed a membrane with a 
surface which was flat. A membrane that was too thin 
resulted in a concave surface which was undesirable. When 
withdrawn from a test solution, an electrode with a concave 
membrane would have fluid retained in the cavity formed by 
the membrane. When immersed in a different solution, this 
residual fluid would act as a diffusion barrier to hydrogen 
ions in the new solution and would reduce the response time 
of the electrode.
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Electrodes suitable for laboratory studies were 
easily produced by filling a 5-10cm length of PVC tubing, 
upon which a membrane had been cast, with O.lM pH7 Tris/HCl 
buffer (115). pH 7 buffer was used as the internal filling 
solution because when immersed in pH 7 buffer, the 
electrode should ideally have no standing potential. Most 
pH meters are constructed so that when an electrode is 
immersed in pH 7 buffer, the potential difference 
registered on the meter is zero millivolts. If the 
electrode was filled with pH 5 buffer, for example, the 
approximately 116mV potential difference generated between 
the internal and external buffer solutions would probably 
be too large to be offset by the average pH meter. However, 
this was not a problem if changes in pH were measured on a 
normal voltmeter but was important when the electrodes were 
used with pH meters in clinical experiments. The use of pH 
7 buffer appeared to have no deleterious effects on 
electrode performance, despite the recommendation of pH 5 
(99) or pH 5.6 (112) buffer as the internal solution. A 
chlorided silver wire soldered onto a screened cable was 
inserted in the open end of the tubing which could be 
sealed to the cable with adhesive if desired. These 
electrodes reguired no pre-conditioning and could be 
immediately used.
Catheter-type electrodes, suitable for in vivo gastro­
intestinal pH measurements, had to be as thin as possible 
to prevent them from interfering with the movement of the 
Crosby biopsy capsule to which they would be attached. The 
electrodes also required a fluid resistant seal between the
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plastic and the cable to avoid short-circuiting the 
electrode. The design of these electrodes was therefore 
more complicated (Figure 1). A 1cm length of 0.5mm silver 
wire was soldered to the exposed inner core of a 2 metre 
length of screened cable (Belden 8700, 1.27mm o.d.;
Wadsworth Electronics Ltd.). A thin covering of silicone 
rubber adhesive (RTV 102; General Electric, UK.) was used 
to insulate the solder joint from the outer screening of 
the cable. After 24 hours, during which time the silicone 
rubber dried, a 1cm section of PVC tubing (2mm o.d.) was 
used to cover the silicone rubber and extend approximately 
3mm beyond the end of the cable's protective PVC jacket. A 
slightly longer length of heat-shrink plastic (2.4mm o.d.; 
R.S.Components, UK.) was positioned over the PVC tubing and 
heated with a soldering iron. As the heat-shrink plastic 
contracted, it formed a mould for the underlying PVC tubing 
which melted during the heating process. When cool, the 
hard mould was carefully cut open with a scalpel blade 
exposing the now solid PVC coating which encapsulated the 
solder joint; this provided further insulation and strength 
to the joint.
To expose the silver wire, which had been totally 
covered by the molten PVC during the heating procedure, the 
PVC capsule was cut back to within 2mm of the silicone 
rubber. Since it was now possible for fluid to seep between 
the cut PVC and the silver wire, the joint was dipped in a 
solution of Lacomit varnish (Agar Aids Ltd.; Stansted, 
England) which sealed the plastic-wire junction. A 2-3mm 
section of silver wire was scraped clear of varnish and
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Figure 1. Method of constructing a plastic pH electrode for use in 
clinical experiments.
CABLE INSULATION SILVER WIRE
SCREENING SOLDER
SILICONE RUBBER
BUFFER
*
HYDROGEN 
ION- SENSITIVE 
MEMBRANE
chlorided for approximately 20 seconds. A 5mm piece of PVC 
tubing with a hydrogen ion-selective membrane on one end 
was filled with pH 7 Tris/HCl buffer and positioned over 
the chlorided silver wire. The junction between the tubing 
and the PVC capsule was sealed with cement prepared by 
dissolving fragments of PVC tubing in excess 
tetrahydrofuran. The opposite end of the cable was 
connected to a suitable plug and the electrode was then 
ready for use.
On the basis of the foregoing technique of electrode 
construction, electrodes could be modified to suit specific 
requirements. By inserting a ceramic plug into the end of 
the PVC tubing (100) prior to casting the membrane by the 
dip technique, electrodes with rigid sensing tips could be 
produced. These electrodes were ideal for passing through 
the lumen of naso-gastric tubes or down the biopsy channel 
of an endoscope. Another type of electrode had a membrane 
sited in the side rather than at the end of the PVC tubing. 
A hole, 1mm in diameter, was cut in the side of a length of 
PVC tubing, 3mm from the end. The membrane was cast by 
smearing a small volume of the membrane mixture over the 
side hole and allowing the excess solvent to evaporate. The 
end of the tubing was sealed with PVC dissolved in 
tetrahydrofuran and the plastic tip could be connected to a 
cable in the manner described above. This type of electrode 
could be used in parallel with other electrodes to provide 
a string of electrodes for measuring pH at pre-selected 
distances down the intestinal tract. With the membrane in 
the side of the electrode, it is easier to produce a
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streamlined device which would not have unsecured pH tips 
(17) snagging the mucosa as it passed down the intestine.
Once the electrode had been constructed, all that 
remained was to examine the functional characteristics of 
these electrodes. For this purpose, the small laboratory 
style electrodes described earlier were used. The following 
section describes the experiments undertaken and the 
results of those experiments.
2 iv) SharflgteEisation Ol plastic electrodes
To determine their characteristics, plastic pH 
electrodes were used in conjunction with a calomel 
reference electrode immersed in a solution of saturated 
KC1. The KC1 reservoir and the test solution were 
electrically connected with an agar bridge (3mm o.d? 3% 
agar in 3M KC1). The calomel and pH electrodes were 
connected to a high impedance electrometer (Keithley 610C) 
and all measurements were made in millivolts at ambient 
temperature.
The response of the plastic electrodes to different 
buffering ions in solution was investigated. Solutions of 
citrate, phosphate, bicarbonate, tris(hyroxymethyl)amino- 
methane (Tris), and phthalate buffers were made in the 
laboratory according to the formulae in reference (115); 
their composition is detailed in Appendix 1. Commercially 
available buffer (BDH) based on potassium hydrogen 
phthalate (pH 4.0; 0.05M) was used for comparison with 
freshly made phthalate solutions.
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The experimental procedure involved titrating the 
selected buffer between pH 3 and 11 with 0.IN HC1 or NaOH. 
The pH change, as measured by a standard laboratory glass 
pH electrode with a combined reference electrode {Py e- 
Unicam 40/E7) connected to a pH meter (Corning EELS), was 
compared with the voltage change recorded by the plastic 
electrode.
In the presence of bicarbonate, citrate, phosphate and 
Tris buffers, the potential difference generated by the 
ion-selective carriers was pH dependent. The change in 
potential difference of TDDA electrodes to changes in 
hydrogen ion activities was close to the theoretical 
maximum (58mV/pH unit) when the selected buffer was 
titrated within the range of pH 4-11 (Figure 2). A 
diminished response was measured either side of this range, 
particularly in the acid region. In contrast, the response 
of OCPH electrodes depended on the buffering ion in 
solution (Figure 3). In bicarbonate and phosphate buffers, 
a pH sensitivity of more than 50mV/pH unit was measured in 
the range of pH 5.5-10, while in Tris and citrate buffers 
the ranges over which this level of sensitivity could be 
measured were pH 4-7 and pH 4-6 respectively. When compared 
to OCPH electrodes, TDDA electrodes had a wider operative 
pH range independent of any buffering ions in the solutions 
tested so far.
The response of OCPH electrodes in laboratory made 
phthalate buffers was extremely unstable while no response 
was measured in commercial phthalate buffers (Figure 4). An
32
mV
 
(T
DD
A 
E
le
ct
ro
de
)
Figure 2. Response of TDDA plastic pH electrodes to citrate ( X ),
bicarbonate ( • ), phosphate Co ) and Tris ( o } buffers.
200
100H
100H
-200H
7 8 96 10 115
pH(Glass Electrode)
Figure 3. Response of OCPH plastic pH electrodes to citrate ( X ),
bicarbonate ( • ), phosphate ( □ ) and Tris ( o ) buffers.
200
100H
~o
pH (Glass Beet rode)
Figure 4. Response of TDDA ( o ) and OCPH ( □ ) plastic pH 
electrodes to commercial phthalate (shaded) and laboratory made 
phthalate (open) buffers.
100n
0-
<b
*o01
lU
■5“100a
a!
>
E
- 200-
-300 T
u 8
T
9 10 11
pH (Glass Electrode)
unstable response was characterised by large fluctuations 
in the recorded potential with time at constant pH values. 
The response of TDDA electrodes in both types of phthalate 
buffer was less unstable than OCPH electrodes. Despite 
this, measurements could not be made with any degree of 
accuracy. Evidently, unstable membrane potentials are the 
result of lipophilic buffer ions interacting with the lipid 
solvent phase of the plastic membranes (99) making accurate 
pH determinations impossible under these circumstances. 
Therefore, perfectly functioning electrodes may appear not 
to be working if calibrated in phthalate buffers.
Electrode resistance was measured with a Keithley 
(610C) electrometer, which is equipped with an ohm-meter 
facility, while the electrode was immersed in pH 7 Tris/HCl 
buffer. The measured resistance was of the order of 1-10 
megohms for TDDA electrodes and 10-100 megohms for OCPH 
electrodes. Omission of sodium tetraphenylborate from the 
TDDA based plastic membranes increased resistance tenfold.
Response time was measured by transferring the pH and 
reference electrodes from a pH 7 to a pH 5 buffer and 
following the response on a paper chart recorder 
(Speedomax) set at a rate of 30cm/minute; the buffers, at 
20® C, were stirred continuously* Sensitive electrodes 
typically gave 90% of their final value within one second 
and reached a stable potential within 15 seconds. Thus, 
plastic electrodes have a fast response time to changes in
pH.
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Electrode drift was measured by leaving the electrode 
in a pH 7 buffer for periods of up to 48 hours. The 
potential was recorded throughout and a chart recorder set 
at a rate of lcm/minute monitored the potential change. The 
container of buffer was sealed at the start of the 
experiment to prevent evaporation of water and the pH of 
the buffer was measured with a glass electrode before and 
after the experiment. A representative value for drift was 
3mV/24hrs which, for an electrode with a pH sensitivity of 
58mV/pH unit, is 0.05 pH units/24hrs. This is a very low 
value of drift for which corrections could easily be made 
at the end of any experiment.
The selectivity coefficients were measured for 
hydrogen over sodium and potassium ions, the two major 
interfering cations of physiological significance. 
Electrode selectivity was determined using the fixed 
interference method (116). A IN solution of the interfering 
cation at a pH of 11-12 was titrated with IN HC1 in the 
presence of the plastic electrode and a glass pH electrode. 
The solution, at ambient temperature, was stirred 
continuously as the pH was titrated to pH 9-7.
When the potential difference of the plastic electrode 
was plotted against the measured pH (Figure 5 and Figure 
6), two regression lines were drawn, each through the 
linear portions of the plotted results. By extrapolating 
the regression lines until they intersected each other, a 
value of activity of the primary ion (Aa) was obtained. 
This activity represented the activity of the primary ion 
at which the contribution by the interfering ion, to the
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generated potential, was such that any further change in 
potential difference due to a reduction in the 
concentration of the primary ion was negligible* The value 
of Aa is used to calculate Kai), the selectivity coefficient 
of the primary ion, a, over the interfering ion, b, from 
the equation:
Kab=Aa/(Ab) V 2b
where z is the charge on the ions, A^, the activity of the 
interfering ion, b, is assumed to be equal to the 
concentration of b in the solution which in these 
experiments was IN.
Measured selectivity coefficients for TDDA electrodes
were extremely high at 10-H*® for sodium (Figure SB) and
I q -11.6 for potassium (Figure 5A). These values are
probably more accurate than previously reported (112)
*
values. By titrating with lOmM HC1, as opposed to IN HC1, 
selectivity coefficients of lO-1^  for sodium and 10™^*^ 
for potassium were obtained, both remarkably similar to 
reported values. The discrepancies can be attributed to 
substantial dilution of the test solution with lOmM HC1, a 
factor not associated with the use of IN HC1*
OCPH electrodes have a relatively poorer selectivity 
for hydrogen ions over other monovalent cations. Measured 
selectivity coefficients of 10"7,0 for sodium (Figure 6B) 
and 10"6#2 for potassium (Figure 6A) would suggest, 
contrary to published observations (99), that these 
electrodes are susceptible to interfering cations even when 
these are present in relatively low concentrations.
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In conclusion the functional characteristics of two 
hydrogen ion-selective easier s ftaye jpeen compared with 
each other and their suitability for use in plastic"T ‘ ; '-(!■■■
electrodes has been assessed- TPPA e^.ec};rodes responded
' I ' ’
over a wider pfj range than QCPft electrodes. The pH range of
1 < 1 ■
TDDA electrodes extends into fcjhe more alkaline region of 
physiological pii yalues and WPuld be more suited to the 
measurement of intestinal pH than OCPH electrodes. Further, 
the selectivity of hydrogen ions oyer sodium and potassium 
ions is greater -for TDDA electrodes than OCPH electrodes. 
In intestinal secretions where the activity of sodium ions 
is relatively high, TDDA electrodes are less likely than 
DCFH electrodes to suffer from cation interference. For 
these reasons, the hydrogen ion-selective carrier tri-n- 
dodecylamine was chosen as the ionophore to be incorporated 
into plastic pH electrodes for clinical investigations. The 
functional characteristics of TDDA electrodes are as good 
as glass pH electrodes within the physiological range of 
pH. Consequently, plastic electrodes based on the TDDA 
ionophore are adequate substitutes for glass pH electrodes 
with the added benefit of being robust yet flexible. 
Unfortunately, the failure of the electrodes to measure 
below pH 4 negated their use at endoscopy for gastric pH 
measurements.
In an earlier ^section the construction of a plastic pH 
electrode for use in conjunction with a Crosby capsule was 
described. It has been shown in this section that the 
characteristics of the ionophore selected for incorporation
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into the plastic electrode are ideal for intestinal pH 
measurements. The following section describes clinical 
investigations using these electrodes. In addition, the 
method of measuring gastric and duodenal surface pH will be 
detailed.
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SLINICAL investigations
Before describing the clinical experimentation, it is 
important to examine some technical problems which have 
caused confusion in the past (117). The present section is 
an attempt to confirm that the experimental technique used 
throughout the clinical investigations is indeed valid and 
to show that the confusion that exists is largely derived 
from the misinterpretation of previously published work 
(12,67) .
3 i)Should combined &L separated electrodes used?.
The selected methods of measuring gastrointestinal 
surface pH in this project required separate reference 
electrodes. To measure mucosal surface pH at endoscopy, the 
pH electrode was passed down the biopsy channel of the 
endoscope. This biopsy channel was not sufficiently large 
to accommodate a combined pH and reference electrode. For 
this reason, a reference electrode was placed in the buccal 
cavity. A buccal reference electrode was also used when 
intestinal surface pH measurements were made at jejunal 
biopsy. Although the reference electrode could have been 
combined with the pH electrode it would have increased the 
overall size of the measuring device. An increase in the 
size of the system was undesirable since it was likely that 
this would disrupt the smooth passage of the capsule- 
electrode assembly through the intestine.
The validity of using separate recording electrodes for 
gastrointestinal pH measurements has previously been 
investigated (12,15). The potential difference between an
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electrode in the stomach and a skin reference electrode was 
approximately 40-60mV more negative than potentials 
registered when the enteric electrode was positioned in the 
oesophagus or duodenum (12). Thusf if a skin reference 
electrode is usedr allowances have to be made for what is 
assumed to be a transmural potential difference. In 
contrast, the potential difference between two enteric 
electrodes separated by upto 15mm has a mean value of OmV 
(12). Consequently, the use of a separate skin reference 
electrode is perhaps questionable when measuring pH in 
different areas of the gastrointestinal tract because of 
the liklihood of varying transmucosal potential differences 
having a distorting influence on the recordings. However, 
a separate enteric reference electrode would appear to have 
no effect on the recorded potential difference.
To make measurements of mucosal surface pH in this 
project, the electrodes would be separated by lm or more, 
although both electrodes would be in contact with the 
enteric mucosa. What effect such a large separation would 
have on the recorded potential was uncertain.
To investigate if this could be a source of systematic 
error, a series of experiments were undertaken. These 
experiments were concerned with the following questions: a) 
does physical separation affect the recorded potential 
difference between two electrodes? b) is there any change 
in this potential difference when the same experiment is 
performed in the gastrointestinal tract? and c) could a 
local electrical field, possibly generated by the mucosa,
39
interfere with the recorded potential?
3 ii) The effect of. .separate recording electrodes on the 
measured pH.
The effect of physical separation of a glass pH 
electrode and its reference electrode was simulated on the 
bench. Three beakers containing pH 7 buffer were joined by 
two buffer filled 1.5m lengths of PVC tubing (2mm i.d.). 
The voltage between the pH and reference electrodes, when 
immersed in the first beaker, was compared to that obtained 
by moving the pH electrode to the second and third beakers. 
No change in potential difference between the electrodes 
was measured with a separation of 1.5m and at 3m separation 
the potential difference changed by lmV; this represented 
an insignificant change in pH.
In addition to the laboratory test, the effect of 
electrode separation on recorded pH was investigated In 
vivo. During endoscopy, the potential difference between a 
reference electrode in the buccal cavity and a reference 
electrode placed in several regions of the stomach and 
duodenum was measured in ten patients. The potential 
differences between areas within the same patient were not 
consistent and a maximum variation of 39mV was measured in 
one patient. However, the change in potential difference 
from the mouth to the duodenum was not linear with distance 
(Table 1). An average of the potential differences recorded 
between electrodes in all ten patients was not 
gigificantly different from zero in all areas. Thus, 
electrode separation would not influence the recorded pH 
when the reference electrode is in the buccal cavity.
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Variations in potential difference are probably the 
result of changing ionic composition under the gastro­
duodenal reference electrode. Changes in ionic composition 
will affect the junction potential of a reference electrode 
but since pH electrodes only respond to changing activities 
of hydrogen ion, changes in the activities of other ions 
will not affect the recorded pH under physiological 
conditions.
Since the gastrointestinal mucosa is a secretory 
tissue, localised potential differences may be generated by 
ion fluxes or separation of electrical charges. The effect 
of a local potential difference on the recorded pH was a 
possible source of error which had to be taken into 
consideration. To simulate these conditions, a pH and 
reference electrode were placed in a pH 7 buffer while a 
voltage from a variable voltage generator was applied 
between two inert reference electrodes in the same buffer 
solution. There was no change in recorded pH when a 
potential difference of 0-1V was applied across the two 
reference electrodes. Local potential differences within 
the gastrointestinal tract would not therefore influence 
the recorded pH.
As a result of these investigations, it was concluded 
that the pH values recorded in the surface measurements 
were not affected by artifacts derived from using separate 
recording electrodes. Further, local tissue potentials are 
also unlikely to affect the recorded pH. It may even be an 
advantage to use a system where the reference electrode is
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maintained in one place. With a combined electrode, the 
ionic composition of the fluids with which the reference 
electrode comes in to contact will change as the electrode 
moves from the stomach to the duodenum. As suggested above, 
changes in ionic composition may cause variations in 
electrode junction potentials, thereby affecting the 
recorded pH. Without being able to compensate for these 
changes in junction potential, the accuracy of pH 
recordings from different areas using a combined reference 
electrode is questionable.
What follows is a description of the clinical 
procedures used for measuring gastrointestinal surface pH, 
beginning with a report on the patients who were used for 
the investigations.
3 iii) Eatlent groups
a) Biopsy Groups: Investigations were performed with the 
patients' informed consent. Jejunal surface pH measurements 
were made in patients referred for jejunal biopsy for the 
investigation of possible small bowel disease or for 
assessment of treatment in cases of previously diagnosed 
coeliac disease. A total of seventy patients were 
investigated but jejunal pH measurements were successfully 
obtained in only forty seven. The unsuccessful 
investigations were mostly attributable to the capsule 
failing to leave the stomach. From the successful 
investigations, three patient groups could be adequately 
defined. These consisted of a control group of 9 patients 
with no evident upper gastrointestinal reason for their
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symptoms, a coeliac group of 13 patients, and 11 patients 
with irritable bowel syndrome (IBS) with no signs of upper 
gastrointestinal disease but whose symptoms improved with a 
high fibre diet. The remainder consisted of patients with 
definable but uncommon illnesses, the small number of which 
precluded statistical analysis, and patients with small 
bowel disease still eluding a conclusive diagnosis at the 
time of study.
Patients in the jejunal biopsy investigations consisted 
of mainly women with two men in each of the patient groups. 
All groups were matched with respect to age with an average 
of 32 years (range 17-58 years) for the control group, an 
average of 33 years (range 21-54 years) for the coeliac 
group and an average of 36 years (range 15-59 years) for 
the IBS group.
b) Endoscopy Groups; Upper gastrointestinal pH measurements 
were made in two series of unselected patients attending 
for endoscopic examination. One series of 82 subjects 
received an injection of atropine (atropine sulphate 0.6mg 
i.m.) prior to endoscopy and are referred to as the 
atropinised series of patients. The other series of 164 
patients received no atropine and are accordingly referred 
to as the non-atropinised series.
Within each series, patients were sub-divided according 
to the eventual diagnosis. Sub-groupings by disease 
consisted of controls, gastritis, gastric ulcer, 
duodenitis, duodenal ulcer, hiatus hernia, oesophagitis and 
pernicious anaemia. However, there was considerable overlap
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of disease groups and some categories selected here may be 
facets of one disease.
In addition, a separate series of pH measurements were 
made in 22 subjects who were undergoing endoscopic 
cannulation for pancreatic and gall bladder dysfunction but 
who otherwise had normal upper gastrointestinal function.
In the non-atropinised and the atropinised series of 
endoscopy patients, 55% of the patients in each series were 
male. Details of the age structure for each group are to be 
found in Appendix 2.
3 iv) Measurement jejunal surface pH.
By combining an electrode with a Crosby capsule, 
histological and functional information was obtained during 
the same investigation. Catheter-type plastic pH electrodes 
based on the tri-n-dodecylamine carrier were used for this 
study. The flexible tip of the electrode was positioned 
against the metal capsule (Figure 7) and aligned so that 
the sensing membrane was almost perpendicular to the 
intestinal mucosa as the capsule passed through the 
proximal small bowel. Securing the capsule suction line to 
the electrode cable with PVC cement ensured that the 
overall dimensions of the assembly were not significantly 
increased. Not only was this reassuring for the patient but 
capsule transit was unimpeded and the proportion of 
unsuccessful biopsy investigations was unchanged.
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The reference electrode consisted of a Pye-Unicam 
(340) Ag/AgCl glass electrode with a porous ceramic plug. 
This was immersed in a solution of 3M potassium chloride 
from which an agar bridge (3M KC1 in 3% agar; o.d. 1.6mm) 
was led to the patient's buccal mucosa. The pH and 
reference electrodes were coupled to the input channel of a 
battery powered pH meter (Knick Portamess 654) whose 
continuous output was monitored by a paper chart recorder 
(Watanabe Servocorder).
An operating system based on a data logger (Grant 
Squirrel SQ8) was used as an alternative recording 
mechanism when two patients were studied simultaneously. 
The data logger replaced the pH meter and pen recorder but 
all other experimental conditions remained the same. 
Results were recorded on the data logger at 15 second 
intervals and the logged information was subsequently 
transferred to a computer (Apple lie) for storage and 
analysis. Comparison of paper chart and data logger 
recordings indicated that similar pH values were obtained.
The electrode system was calibrated in citrate (pH 5) 
and Tris (pH 7 & 8) buffers before and after each
experiment. Recordings were made in millivolts which were 
converted to pH by reference to the calibration buffers 
and, if need be, corrected for drift on the assumption that 
electrode drift was linear with time.
The experimental procedure differed little from the 
jejunal biopsy regime routinely used in the investigation 
unit. After the patient had swallowed the capsule assembly,
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Figure 7. Method of attaching a plastic pH electrode to a Crosby
biopsy capsule. Scale is in centimetres.
the electrodes were connected to the monitoring equipment 
and a continuous recording initiated. Movement of the 
electrode from the stomach to the duodenum (Figure 8) was 
verified by fluoroscopy and was always characterised by a 
rise in pH from acidic to near neutral values. The 
capsule's progress was subsequently monitored by 
fluoroscopy at half hourly intervals. Continuous 
measurements of mucosal surface pH were made until the 
capsule was distal to the ligament of Treitz, the 
anatomically accepted junction between duodenum and 
jejunum. At this point, a biopsy was taken whilst still 
recording the mucosal surface pH. In this way, the pH of 
the mucosa was measured as close to the site of biopsy as 
possible and during suction.
After retrieval, the excised tissue was removed from 
the capsule and the specimen was halved? one portion was 
placed in Bouin's fixative for histological examination, 
the other was weighed and stored at -5°C prior to the assay 
of disaccharidase activities by the method of Dahlqvist 
(118) .
3 v) Measurement of gastric StttfflCe piL>
Flexible fibre-optic endoscopes allow convenient access 
to the upper gastrointestinal tract. Under direct visual 
control, the tip of the endoscope can be positioned in all 
regions of the stomach and up to the papilla of Vater in 
the duodenum. The endoscope used in this investigation was 
an Olympus GIF-1T panendoscope (forward viewing) with a 
biopsy channel of 3.7mm in diameter, sufficiently large to 
accommodate the smallest commercially available glass pH
46
E
iq
ur
sft
 
A 
R
ep
re
se
nt
at
iv
e 
R
ec
or
di
ng
 
of 
Su
rf
ac
e 
pH 
Fr
om
<a
 
Pa
tie
nt
 
at 
Je
ju
na
l 
B
io
ps
y
Q_
XJ
~o
XCL
electrode.
The electrode was a catheter-type glass pH electrode 
(Oesophageal pH probe MI-506; Microelectrodes Inc., New 
Hampshire, USA) with a maximum diameter of 1.6mm. The 
electrode was used in conjunction with the reference 
electrode and pH meter used for jejunal pH measurements. 
The system was calibrated in pH 7 and 4 phthalate buffers 
prior to the endoscopy session and the electrode was zeroed 
in pH 7 buffer between individual investigations; on 
average each endoscopy session provided three or four 
suitable patients.
Patients were sedated with Diazemuls (KabiVitrum Ltd., 
UK.; 10-20mg i.v.) immediately before the endoscope was 
passed. The co-operating physicians examined the patient 
and concluded with the endoscope in the second part of the 
duodenum, proximal to the papilla of Vater. At this stage 
the pH electrode was advanced down the biopsy channel. The 
reference electrode was inserted into the patient's mouth 
and held against the buccal mucosa. The pH in six regions 
of the gastrointestinal tract was then measured (Figure 9). 
These were the second part of the duodenum (referred to as 
the duodenal loop), the duodenal cap, the pyloric channel, 
the greater curvature of the pre-pyloric antrum, the cardia 
of the fundus on the greater curvature, and 5cm proximal to 
the Z-line of the gastro-oesophageal junction. Within each 
region the tip of the electrode was positioned against the 
mucosa until a stable pH reading could be obtained. The 
electrode was then removed from the mucosa and allowed to
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Figure 9 Positions within the stomach and
duodenum from where pH measurements 
were made.at endoscopy.
Endoscope |
vj;
Electrode
Duodenal 
loop
Duodenal 
cap
Pylorus v
Oesophagus 
Fundus
Antrum
contact any surrounding luminal fluid. A second mucosal 
reading was made to obtain an average value of mucosal pH. 
The procedure was repeated in the next region until all 
areas had been measured.
Atropinised patients did not have the pH measured in 
the duodenal loop and those at ERCP (endoscopic retrograde 
cholangio-pancreatography) had only the duodenal cap and 
loop measured; the side-viewing JF-1T Olympus endoscope 
used at ERCP is unsuitable for gastric pH measuring. In 
addition to a sedative (Diazemuls), ERCP patients also 
received pethidine (Roche; 50mg i.v.) , a short lasting 
analgesic.
3 vi)Statistical analysis
Examination of past and present papers on gastro­
intestinal pH will reveal several different ways of 
expressing pH data for statistical analysis. Confusion 
exists (19,119) about the correct way to analyse the data 
because pH is a logarithmic term. When pH is converted into 
hydrogen ion activities the distribution of data may become 
skewed. It is often assumed that because this skew is 
present in the transformed data, it is unjustifiable to 
treat the pH data as a normally distributed sample. 
However, the response of a pH electrode, which is described 
by the Nernst equation, is linearly related to the log of 
the hydrogen ion activity of the solution under examination 
(120) and will be normally distributed when randomly 
sampled (121). Therefore it is quite justifiable to use 
statistics for normal distributions when analysing pH data. 
That is not to say that pH data cannot be skewed, since
48
under physiological conditions, non-normally distributed 
data sometimes arise. The occurrence of skew on the 
distribution of pH data can be dealt with using non— 
parametric statistics.
Statistical treatment of pH data collected front the 
clinical investigations in this project was as follows. 
Each group of pH values was tested for the presence of 
significant skew and kurtosis. Comparisons of all patient 
groups was by "Student's” t-test if no abnormality in the 
sample distributions was detected. Tests on the equality of 
variance between patient groups was performed using the F— 
test statistic and the appropriate t-test using either 
pooled or separate variances was used. If any one group of 
values was not normally distributed, all comparisons with 
that group were performed using Mann-Whitney or chi-squared 
non-parametric statistics. Stated values in the text are 
the mean value for a disease group variable and the 
standard error of that mean while given significance levels 
refer to t-tests, unless otherwise stated. Implementation 
of all statistical analysis was by BMDP (122) and Minitab 
(123) programmes available on an ICL 2976 computer.
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CLINICAL RESULTS
Using the methods described in the preceding section, 
it was possible to measure the mucosal surface pH from the 
oesophagus to the proximal jejunum in humans in vivo. 
Because the study was not restricted to measuring mucosal 
surface pH in healthy control patients but was also 
extended to examine diseased patients, it is possible to 
assess if any changes in mucosal surface pH occur in 
disease states. The following analysis of results starts 
with the jejunal surface pH measurements and continues with 
a more extensive section on gastro-duodenal surface pH 
measurements.
4 i) Proximal .small bfiwsl fijarfagg EH.
In this study, the mucosal surface pH was continuously 
measured from the proximal duodenum to the proximal 
jejunum. The duodenal mucosal surface pH (Figure 10) 
measured at jejunal biopsy in a series of control patients 
without functional gastrointestinal disease was 
6.76+0.16(9), not significantly different from neutrality. 
As the electrode progressed down the proximal intestine, 
the pH fell towards more acid values. The jejunal surface 
pH (Figure 11), measured at the site of biopsy, was 
5.90+0.10 in nine control patients and was significantly 
(p<0.001) more acid than neutrality. These results show 
that a pH gradient exists down the proximal small bowel of 
control patients, the pH becoming more acid the further 
along the bowel the electrode records. No inferences about 
the surface pH of more distal regions can be made from this 
study, although there is no reason why this system for
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Figure 10. Duodenal surface pH measured at jejunal biopsy. Coeliac 
patients were either on a normal diet (ND) or a gluten free diet 
(GFD). Number of patients in parentheses.
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Figure 11. Jejunal surface pH measured at jejunal biopsy in control 
and coeliac patients. The coeliac group consists of patients on a 
gluten free diet (GFD) or a normal diet (ND) and patients with a 
normal mucosa (NM) or with villous atrophy (VA). Number of 
patients in parentheses.
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measuring surface pH cannot be extended to measuring ileal 
mucosal surface pH.
Coeliac patients are a suitable group of people for 
comparison with the control state since the disease is 
associated with intestinal derangement. The stunted jejunal 
villi characteristic of coeliac disease respond favourably 
to a gluten-free diet. This allows a distinction to be made 
between treated and untreated patients. The duodenal 
mucosal surface pH (7.36+0.13) in eleven coeliac patients 
was significantly (p<0.01) more alkaline than that of 
control patients (Figure 10). No difference between 
patients on (7.34+0.17(7)) or off (7.40+0.22(4)) a gluten- 
free diet could be established. In the jejunum, coeliac 
patients had a mean surface pH of 6.73+0.15(13) which was 
not significantly different from neutrality and was 
significantly (p<0.001) less acid than the control group 
(Figure 11). Four of the coeliac patients on a normal diet 
had an almost neutral surface pH of 6.95+0.33 which was 
significantly (p<0.01) more alkaline than the control 
group. However, the remaining nine treated coeliac patients 
also showed a significantly (p<0.005) elevated jejunal 
surface pH of 6.63+0.15(9) when compared with the control
group.
alternative sub—division of the coeliac patient data 
is by the appearance of the mucosa. Eight coeliac patients 
with partial or sub-total villous atrophy had a jejunal 
surface pH (Figure 11) of 6.84+0.22 which was more alkaline 
(p<0.00 5) than the control value. The remaining five
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patients with a mucosa of normal appearance were still 
significantly (p<0.01) more alkaline (6.56+0.13(5)) than 
the control subjects. From this data it appears that 
alterations in surface pH persist despite coeliac patients 
having a structurally normal jejunal mucosa.
A third, relatively large, group of patients was 
identified from within the experimental population. These 
patients had irritable bowel syndrome (IBS) which, although 
not associated with tissue structural damage, is often 
characterised by irregularities in bowel movements and 
stool consistency. In the duodenum (Figure 12a), the 
mucosal surface pH of four IBS patients was 6.23+0.25, not 
significantly different from the duodenal surface pH of 
control patients. Unlike control patients, there was not 
such a noticeable pH gradient from the duodenum to the 
jejunum where a mean surface pH of 6.10+0.07(6) was 
recorded. The jejunal surface pH was not significantly 
different from control values (Figure 12b). In addition to 
the six IBS patients on a high fibre diet, five further IBS 
patients were also taking mebeverine (Colofac; Duphar 
Laboratories Ltd.), an anti-spasmodic drug for reducing 
intestinal motility, prior to investigation. In this sub­
group of patients, the duodenal surface pH (7.47+0.23(3)) 
was significantly (p<0.05; U-test) more alkaline than 
control duodenal pH values and significantly (p<0.03) more 
alkaline than the duodenal surface pH of IBS patients not 
receiving mebeverine. In the jejunum, the mebeverine 
treated group of patients (Figure 12b) had a mean jejunal 
surface pH of 6.58+0.15(5) which was significantly (p<0.01)
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Figure 12. (A) Duodenal and (B) jejunal mucosal surface pH of
patients with irritable bowel syndrome (IBS) either with or without 
mebeverine (meb) pretreatment. Number of patients in parentheses.
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higher than the mean of 6.10+0.07(6) from IBS patients not 
treated with mebeverine. It was also significantly 
(p<0.001) less acid than control values for jejunal surface 
pH. This suggests that either the local anti-spasmodic 
effects of mebeverine or some other property of the drug 
can influence the mucosal surface pH.
The measurements of mucosal surface pH have been 
expressed only in relation to the appearance of the jejunal 
tissue and with respect to disease groups. Jejunal tissue 
derangement can be associated with changes in functional 
activity of the tissue; patients with active coeliac 
disease invariably have lower than normal disaccharidase 
levels. Throughout this jejunal surface pH investigation, 
samples of biopsied tissue were assayed for lactase,
maltase and sucrase activities (Table 2). The measured
activities are an alternative index of tissue function with 
which surface pH values can be correlated. There were 
significantly (p<0.01) lower than normal levels of lactase, 
maltase and sucrase activity in the untreated coeliac
patients and patients with villous atrophy. Patients on a
gluten-free diet had higher (p<0.05) maltase and sucrase 
activities than patients on a normal diet. Patients with 
irritable bowel syndrome had normal enzyme activities and 
there was no effect of mebeverine on enzyme activity.
On combining data from all patients, jejunal surface pH 
correlated inversely with lactase (r=0.56; p<0.01), but not 
with maltase (r=0.29) or sucrase (r=0.29) levels. Improved 
correlations were found when the logarithmic values for 
enzyme activities were used. Significant correlation was
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TABLE 2 BISACCHARIDASE ACTIVITIES OF TISSUE EXCISED AT 
JEJUNAL BIOPSY
LACTME MALTASE BU..CRASE
Control(all) 5.14+1.21(9) 25.96+4.16(9) 6.57+1.20(9)
Coeliac(all) 1.42+0.46(13)* 15.79+3.68(13) 4.17+0.95(13)
Coeliac(GFD) 1.82+0.62(9)** 20.02+4.53(9) 5.32+1.12(9)
Coeliac(ND) 0.50+0.15(4)* 6.25+3.03(4)* 1.58+0.95(4)*
Coeliac(NM) 2.60+0.98(5) 26.66+6.66(5) 6.90+1.58(5)
Coeliac(AM) 0.68+0.19(8)* 8.99+2.15(8) * 2.46+0.73(8)*
Irritable
Bowel
6.28+1.08(6) 30.63+4.70(6) 5.86+0.90(5)
Irritable 3.32+1.32(5) 30.46+4.64(5) 8.04+1.02(5)
Bowel + meb
GFD=Gluten-Free Diet, ND=Normal Diet 
NM-Normal Mucosa, AM=Abnormal Mucosa 
meb=mebev er i ne.
* p<0.01; ** p<0.05
observed when log values for maltase (r=0.53? p<0.01) and 
sucrase (r=0.46; p<0.01) were plotted against jejunal
surface pH; taking the log of lactase activity (Figure 13) 
had little effect on the calculated correlation 
coefficient. No correlation was seen in the coeliac group 
alone. The apparent correlation of surface pH with jejunal 
enzyme activity does not imply that one is the result of 
the other. However, it does suggest that a disease which 
results in reduced disaccharidase activity due to tissue 
damage in the jejunum may also be associated with an 
elevated surface pH.
In addition to the three groups of patients already 
described, individual cases or small groups of patients 
with gastrointestinal disease were investigated. 
Alterations in surface pH were most noticeable in patients 
with inflammatory bowel disease. Three patients with long­
standing Crohn's disease had a raised jejunal surface pH 
(6.67+0.27(3)), as did a patient with ulcerative colitis 
(pH 6.8). In comparison, two patients with dermatitis 
herpetiformis had rather acid surface pHs (pH 5.3 & 5.7) 
and a patient with post-vagotomy diarrhoea had a surface pH 
of 5.4. A patient with oral Crohn's which did not affect 
the intestine had an acidic jejunal surface pH of 5.5. 
Thus, the occurrence of an elevated surface pH appears not 
only to be associated with intestinal structural damage eg. 
coeliac disease, but also with inflammatory diseases such 
as Crohn's disease and ulcerative colitis.
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Figure 13. The relationship between jejunal surface pH and Log 
lactase activity (International units per gram wet weight tissue 
(IU/g)) measured in all patients.
r = -0.541; n = 33; p < 0.01
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Jejunal surface pH
This section of the study has shown that small bowel 
tissue derangement can result in changes of duodenal and 
jejunal surface pH. Can such changes in surface pH be seen 
in gastric and proximal duodenal diseases?
4 ii) -Gastric .and RTOXimal duodenal surface pH,
Using the jejunal biopsy procedure it was possible to 
measure proximal intestinal surface pH but not gastric 
mucosal pH values. This was for two reasons: within the 
stomach the electrode could not be maintained against the 
gastric mucosa and secondly, the plastic pH electrode would 
not respond below pH 4. However, it is possible to measure 
gastric surface pH at endoscopy using a glass pH electrode. 
The glass pH electrode can be seen to touch the mucosa 
(Figure 14) and it can be maintained in the appropriate 
position for as long as is necessary to obtain a stable 
recording of pH. Unlike mucosal pH, obtaining luminal pH 
readings was more difficult. When patients were placed on 
their left side for endoscopy, any gastric juice in the 
stomach pooled in the fundus. Consequently, there was never 
any difficulty in obtaining a fundal luminal fluid 
measurement. In areas other than the fundus it was not 
always possible for the electrode to make contact with 
luminal fluid and the recorded pH slowly drifted upwards, 
providing a source of alkaline error. Consequently, some 
caution is required when considering luminal values.
When mucosal and luminal pH readings (Appendices 3 & 4) 
are compared, a difference between recorded values can be 
seen in all regions of the stomach and duodenum (Figure 15)
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Figure 14. A glass pH electrode making contact with the duodenal 
mucosa to obtain a surface pH reading at endoscopy.
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Figure 15. Lumen-mucosa pH differences measured in all investigated 
regions. Number of patients in parentheses. Probabilities refer to 
a significant deviation from zero.
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and in all patient groups (Table 3,4 & 5). Thus, the 
mucosal surface pH can be, and invariably is, different to 
the pH of the fluid perfusing the tissue. A significant 
correlation (p<0.01) exists between lumen and surface pH in 
all regions (Table 6) although this does not necessarily 
imply that one is the result of the other.
The distribution of fundal luminal pH (Figure 16) spans 
a wide range of pH values although it appears that there is 
an "acid secreting" and a "resting" population within the 
total distribution. Acid is implicated as a causative 
factor of ulceration and therefore acid is most likely to 
provoke a mucosal response. For this reason, an alternative 
way of analysing the data was to sub-divide the patients 
into those with a fundal lumen pH above or below pH 3. The 
value of pH 3 was an arbitrarily selected value, although 
any other cut-off point could have been used. For ease of 
description, patients with a pH below 3 are referred to as 
acid secreting patients. This partitioning of the results 
in no way implies that the patients with a low luminal pH 
secrete excess acid, only that at the time of endoscopy 
these patients had acid in the fundus.
ii a) Patients with m  upper gastrointestinal abnormalities
Twenty four patients with no gastric or duodenal 
abnormalities seen at the time of endoscopy were selected 
as a control group for comparison with patients with 
gastrointestinal disease. The measured surface pH in these 
control patients ranged from a maximum of pH 8.1 in the 
antrum and pylorus to a minimum of pH 0.95 in the fundus. 
There was a pH gradient from the fundus to the duodenum
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4 LPMBN-MPCOSA pH DIFFERENCES OF PATTENT flitnnPS
Py Lq.eusPat ient Group 
Normal
Gastritis
Gastric Ulcer
Duodenitis
Duodenal Ulcer
Hiatus Hernia
MEASURED AX ENDOSCOPY
Antrum 
0.18+0.24(24)
0.98+0.46(6)
0.01+0.38(20)
-0.31+0.36(14)
0.40+0.27(22)
-0.90+0.62(4)
0.13+0.20(21)
0.40+0.26(6)
0.22+0.21(18)
-0.06+0.55(11)
0.52+0.23(20)*
0.38*0.14(5)
0.41+0.22(16)
—  4> 4*
0.74+0.15(5)
zero
Oesophagitis -0.33+0.50(16)
Pernicious Anaemia 0.81+0.15(5)
* p<0.05; * p<0.02
significantly different from
TABLE 5. LUMEN-MUCOSA Dfl differences of patient groups
MEASURED AX ENDOSCOPY
Patien t  Group 
Normal
Gastritis
Gastric Ulcer
Duodenitis
Duodenal Cap 
0.60+0.12(23)
-0.51+0.94(6)
0.44+0.06(18)
0.47+0.10(14)
* * *
***
***
Duodenal Loop 
0.48+0.07(22)1
0.43+0.08(4) **
0.40+0.09(18)
0.41+0.10(12)
Duodenal Ulcer 0.20+0.21(21) 0.40+0.08(18)
Hiatus Hernia 0.37+0.23(5) 0.39+0.15(5)
Oesophagitis 0.28+0.35(16)
Pernicious Anaemia 0.70+0.06(5)
* * *
0.54+0.12(13)
0.64+0.14(5)
**
* p<0.02; ** p<0.01; *** p<0.001
significantly different from zero
TABLE 6
GROUP
Oesophagus
Fundus
Antrum
Pylorus
Duodenal 
cap
Duodenal 0.359
loop
NUMBER SIGNIFICANCE
113 p<0.01
115 p<0.01
118 p<0.01
107 p<0.01
114 p<0.01
104 p<0.01
LUMEN"MUCOSA CORRELATION COEFFICIENTS
COEFFICIENT 
0.821 
0.608 
0.824 
0.801
0.337
N° 
of 
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of 
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Figure 16. Frequency distribution histograms of fundal lumen pH 
in (A) non-atropinised and (B) atropinised patients investigated 
at endoscopy.
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(Figure 17). The mean fundal pH of 4.86+0.46(24) was more 
acid than the mean antral (5.63+0.45(24)), pyloric 
(6.99+0.35(21)) and duodenal cap (7.05+0.16(23) and loop 
(7.09+0.09(22)) surface pHs.
For control patients without acid in the fundus (fundal 
lumen pH 5.86+0.59(10)), the mucosal surface pH from the 
fundus to the duodenum was close to neutrality. In 
contrast, when an acid fundal lumen (1.85+0.14(14)) was 
present, the fundal ( 3.82 + 0 .63 (14)) and antral 
(4.67+0.58(14)) mean surface pHs were significantly 
(p<0.001 & p<0.01 respectively) more acidic than neutral. 
These results indicate that the stomach cannot maintain a 
neutral mucosal pH when acid is in the stomach.
However, duodenal mucosal pH was near neutral and very 
similar in both acid and non-acid secreting sub-groups of 
the control population. The luminal pH was more alkaline 
than the mucosa in the pylorus (p<0.001), duodenal cap 
(p <0.01) and duodenal loop (p<0.05) when no acid was 
present in the stomach. When acid was present, only the 
luminal pH in the duodenal loop was more alkaline (p<0.01) 
than the mucosal pH. Thus the duodenum is capable of 
maintaining a neutral surface pH while the stomach secretes 
acid and when the fluid in contact with the mucosa is 
alkaline. Whether a neutral surface pH can be maintained at 
the duodenal mucosa when the tissue is directly challenged 
with acid cannot be determined from this study.
The duodenal mucosal pH was also neutral when measured 
at ERCP. The purpose of this pilot study was to see what
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Figure 17. Mucosal surface pH of all investigated areas of control 
patients ( • ) and in control patients with a fundal lumen pH < 3 
(X) or pH > 3  (o). Numbers refer to the number of patients in 
each group.
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effect a reduction or a complete absence of biliary 
bicarbonate would have on duodenal surface pH. The surface 
pHs in the duodenal cap (7.06+0.07(22)) and duodenal loop 
(6.91+0.09(22)) were not significantly different from pH 7. 
A comparison between these results and those obtained at 
endoscopy is problematical because of the different 
experimental conditions under which the results were 
obtained. However, it is interesting to note that the ERCP 
results are remarkably similar to the duodenal cap 
(7.05+0.16(23)) and duodenal loop (7.09T0.09(22)) results 
obtained from control subjects at endoscopy.
Since the patients at ERCP generally had common bile 
duct obstruction but little else wrong with them, ie. 
normal upper gastrointestinal function, the values measured 
in the duodenum strengthen the impression that normal 
duodenal surface pH is neutral. Further, bile secretion 
does not necessarily have to occur for the maintainence of 
a neutral surface pH and therefore the surface pH may 
probably be determined primarily through mucosal 
mechanisms. To investigate this further, it would be 
necessary to measure the duodenal surface pH in patients 
with both biliary and pancreatic duct obstruction to 
eliminate any influences exerted by pancreatic bicarbonate 
on duodenal mucosal pH.
The influence of acid on mucosal surface pH was always 
a factor which had to be considered. A separate group of 
five patients with pernicious anaemia were investigated to 
determine what effect the total absence of acid would have
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on the gastric and duodenal surface pH. For comparison, the 
fundal lumen pH in the pernicious anaemia group 
(7.08+0.16(5)) was significantly (p<0.01) higher than in 
non-acid secreting control patients (5.86+0.59(10)). The 
mucosal pH of all areas measured (Figure 18) in pernicious 
anaemia patients was not significantly different from 
neutral. However, the possibility that pernicious anaemia 
may itself affect the mucosal pH cannot be discounted and 
these results should be considered with caution. A possible 
avenue for further investigation would be to measure the 
gastric mucosal pH in pernicious anaemia patients before 
and after bathing the tissue with acid. The ability of the 
mucosa to neutralise the acid could then be assessed and 
compared with earlier findings from control endoscopy 
patients.
Neural control of gastric acid and pepsinogen secretion 
is mediated through vagal stimulation. It is also suggested 
(124) that bicarbonate secretion by the mucosa is partially 
controlled by stimulation of vagal nerve fibres. By 
reducing or inhibiting vagal stimulation with atropine, it 
is possible to examine what effect this has on mucosal 
surface pH. For this part of the study, fifteen patients 
were selected as a control group for the atropinised 
series. A pH gradient from the fundus to the duodenum, 
similar to that seen in the non-atropinised series, was 
also present in the atropinised patients. Although there 
was an underlying trend towards more alkaline surface pH 
values in the atropinised series of control patients, there 
were no significant differences in surface pH when mean pH
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values from atropinised and non-atropinised patients were 
compared (Figure 19).
Out of the total of fifteen atropinised control 
patients, only four patients had a fundal lumen less than 
or equal to pH 3. Comparing patients with and without acid 
in the fundus, fundal surface pH was very similar in both 
groups. However, when no acid was present, the surface pH 
of the fundus in the atropinised series was lower (p<0.001) 
than in the non-atropinised series of patients. The pyloric 
mucosal pH seemed to be most affected by atropine. When no 
acid was present in the fundus, the pyloric surface pH was 
reduced (p<0.01) from 7.62+0.08(9) in the non-atropinised 
series to 7.19+0.11(9) when atropine was given. The reverse 
situation was found when acid was present in the fundus. 
Here, pyloric surface pH rose from 6.52+0.57(12) in the 
non-atropinised series to 7.58+0.25(4) in the atropinised 
series. The luminal pH of the pylorus and duodenal cap were 
more alkaline (p<0.01 & p<0.02 respectively) than the 
mucosa when there was no acid in the stomach. However, 
when acid was present, these differences could no longer be 
measured. This was similar to the results from the non- 
atropinised series. In summary, atropine, in the dose 
administered, could not be shown to have any concerted 
effect on luminal or mucosal pH in control subjects.
The preceding results have shown that although a near 
neutral mucosal surface pH can be measured in the duodenum, 
despite the presence of acid in the stomach, the gastric 
mucosal pH does not maintain a neutral microclimate under 
similar circumstances. If this is what happens in normal
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Figure 19. Mucosal surface pH of control patients either with 
(shaded) or without (open) atropine pre-treatment. Number of 
patients in parentheses.
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patients, what changes in mucosal pH, if any, occur in 
gastric and duodenal ulcer disease? To answer this 
question, pH results from patients with peptic ulcer 
disease were compared with control values.
ii b) Patients ttith gastric Jilcer
From the total population of non-atropinised patients, 
twenty people had a gastric ulcer which was either active 
or at some stage of healing. With the notable exception of 
the antrum, the surface pH of all areas was very similar to 
that of control patients (Figure 20). In the antrum, the 
surface pH of 6.96+0.15(20) in gastric ulcer patients was 
significantly (p<0.01) more alkaline than the mean antral 
surface pH of 5.63+0.44(24) measured in control patients. 
The difference between antral surface pH in the two groups 
became even more significant (p<0.005) when only the acid 
secreting patients were compared (Figure 21). Here, the 
antral surface pH of control patients was 4.67+0.58(14) 
but in the gastric ulcer group, the antral surface pH 
(6.83+0.27(11)) remained elevated and was not significantly 
different from neutral. This near neutral surface pH could 
not be attributed to a higher fundal luminal pH since mean 
fundal luminal pHs in control (1.85+0.14(14)) and gastric 
ulcer (1.69+0.10(11)) acid secreting patients were not 
statistically different. This was true also for antral 
luminal pH values in the acid secreting groups.
When the data from gastric ulcer patients without acid 
in the fundus was examined, a different situation was 
found. Here, gastric mucosal surface pH did not differ from
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Figure 20. Mucosal surface pH in control (closed circles) and 
gastric ulcer (open circles) patients. Numbers refer to the 
number of patients in each group.
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pH values obtained in a comparable control group. Even in 
the antrum (Figure 21), mucosal surface pH in gastric ulcer 
patients (7.11+0.10(10)) was similar to that of control 
patients (6.97^0.43 (10)). Therefore, the antral surface pH 
in gastric ulcer disease is broadly neutral and does not 
differ from that seen in normal subjects when no acid is 
present in the stomach. It is only when acid is present in 
the fundus that the striking antral differences are 
unmasked, with the gastric ulcer group preserving an almost 
neutral antral surface pH while that of control patients 
becomes more acid.
Another way of determining whether this antral 
phenomenon is related to the presence of a gastric ulcer is 
to sub-divide the group into patients with either active or 
healing ulcers (Figure 21). After sub-division the antral 
surface pH of patients with active gastric ulcer disease 
(7.07+0.0 9(14)) is significantly (p<0.004) more alkaline 
than control values. In contrast, the antral surface pH of 
patients with healing gastric ulcers (6.75+0.41(7)), 
although still elevated, is not significantly so. Once 
again, the presence of acid in the stomach accentuates the 
antral surface pH difference (p<0.001) between active ulcer 
patients (7.16+0.16(7)) and control patients 
(4.67+0.58(14)). In patients secreting acid with healing 
gastric ulcers (6.25+0.62(4)) no significant differences 
from normal could be detected. However, without acid in the 
fundus, no difference in antral mucosal pH was noted 
between active and healing, active and control or, healing 
and control patient groups. Thus, an elevated antral
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surface pH in gastric ulcer disease was associated with 
increased ulcer activity and the presence of acid in the 
stomach.
Gastric ulcers were often associated with gastritis 
which was either diffuse or localised around the ulcer. Six 
patients with gastritis only had an antral surface pH of 
6.6 8+0.30(6) which was not significantly different from the 
mean control value (5.63+0.44(24)). But, if only acid 
secreting patients were considered, then patients with 
gastritis (6.50*0.29(5)) had a significantly (p<0.02) more 
alkaline antral surface pH than control subjects 
(4.67+0.58(14)).
If the view is taken that gastritis precedes the 
formation of gastric ulcer, then the evidence presented so 
far suggests that the antral surface pH becomes more 
alkaline as the disease progresses from gastritis to fully 
active gastric ulcer. At the onset of the disease, gastric 
acid must be present for the antral alkalinity to be 
detected but as the disease develops, lower levels of 
acidity are sufficient to stimulate the alkaline secretion 
of the antrum.
In the atropinised series of patients no significant 
differences were detected between control and gastric ulcer 
patients, whether combined into one group or sub-divided 
into active or healing gastric ulcer. Similarly, the 
presence of acid in the stomach (Figure 22) had no effect 
on gastric or duodenal surface pH. However, fundal surface 
pg q £ patients without acid in the stomach was higher
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(p<0.05) in gastric ulcer patients (6.3 9+0.45(7)) than in 
control patients (4.77+0.53(11)) without gastric acid. In 
the antrum of these two patient sub-groups, the mean 
mucosal surface pHs were almost indistinguishable from each 
other.
In the case of gastritis patients receiving atropine, 
five out of the six patients had a fundal lumen above pH 3. 
Within this group of five gastritis patients, the 
oesophageal (7.17+0.47(5)) and fundal (6.95+0.41(5)) mean 
surface pH values were significantly (p<0.05, p<0.01
respectively) more alkaline than control values of pH 
(oesophagus: 5.70+0.3 8(11); fundus: 4.77+0.53 (11)). The
antral surface pH (7.33+0.29(5)) of this gastritis group 
was not significantly different from a control pH of 
6.58+0.35(11).
Atropine pre-medication appears to abolish antral pH 
differences between control patients and patients with 
gastric disease. In contrast, with atropine the fundal 
surface pH becomes more alkaline than normal in gastric 
disease when no acid is present. The reason for this 
apparent switch in areas affected is unclear and perhaps 
requires further investigation.
In summary, gastric ulcer disease is associated with a 
conspicuously elevated antral surface pH when acid is 
present in the fundus. If no acid is present, there is no 
discernable difference in the antral surface pH of normal 
and gastric ulcer patients, and is broadly neutral. There 
is no difference in antral surface pH between acid and non­
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acid secreting gastric ulcer patients. This antral 
phenomenon is seen to a certain extent in gastritis 
patients but is abolished when atropine premedication is 
administered to ulcer and gastritis patients.
ii c) Eatients with duodenal ulcer
Gastric ulcer disease and duodenal ulcer disease are 
often considered to be separate entities. In the light of 
the more alkaline surface pH measured in gastric ulcer 
disease, could such an example of altered surface pH be 
found in patients with duodenal ulcer?
To investigate this, the mucosal surface pH of twenty 
two patients with active duodenal ulcer disease was 
compared with control values (Figure 23). In the fundus, 
the luminal pH of ulcer patients (3.03+0.47(21)) was 
similar to the control value of 3.52+0.48(24) and no 
differences in the gastric mucosal surface pH were noted 
between the two patient groups. Therefore, duodenal ulcer 
disease has no effect on gastric mucosal pH. In the 
duodenal cap, where the majority of ulcers were situated, 
mucosal surface pH (7.26+0.0 8(20)) was significantly 
(p<0.01) more alkaline than neutrality but was not 
s t a t i s t i c a l l y  different from the control pH 
(7.05*0.16(23)). However, in the duodenal loop, duodenal 
ulcer patients (7.20+0.15(17)) did have a more (p<0.01; 
chi-squared test) alkaline surface pH than control patients 
(7.09+0.09(22)).
When only acid secreting patients were compared, 
duodenal ulcer patients had a lower (p<0.02) fundal lumen
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Figure 23. Measurements of mucosal surface pH in control (closed 
circles) and duodenal ulcer (open circles) patients investigated at 
endoscopy. Numbers refer to the number of patients in each group.
p<0*01
 ^ oesophagus fundus antrum pylorus cap loop
duodenum
pH (1.45T0.07 (12)) than control patients (1.85+0.14(14)). 
This was also true of fundal mucosal pH (duodenal ulcer: 
2.32+0.31(12); control: 3.82T0.63 (14) ; p<0.05). Once again, 
in the duodenum (Figure 24), no differences in cap mucosal 
pH were measured but duodenal loop pH in ulcer patients 
(7.35+0.23(9)) was strikingly more (p<0.01; chi-squared 
test) alkaline than in control patients (7.05*0.11 (12)).
Therefore, although duodenal cap surface pH in duodenal 
ulcer patients is significantly alkaline it is no more 
alkaline than that measured in control subjects. In 
contrast, duodenal loop surface pH is substantially more 
alkaline than normal in duodenal ulcer disease. 
Interestingly, while acid in the fundus has virtually no 
effect on the duodenal loop surface pH in normal patients, 
there is a noticeable increase in the duodenal loop surface 
pH of ulcer patients.
Twelve patients who had duodenitis only were also 
investigated. In these duodenitis patients, the gastric and 
duodenal surface pHs were remarkably similar to mean 
control surface pH values, even when acid was present in 
the stomach. This implies that alkalinity can only be 
measured during active duodenal ulceration and not during 
earlier stages of the disease if indeed duodenitis leads to 
ulceration. This is in contrast to gastric ulcer disease 
where the development from gastritis through to active 
ulceration was associated with the appearance of a 
progressively more alkaline antral surface pH.
Atropine pre-medication abolished any signs of
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increased alkalinity in the duodenum of ulcer patients 
(Figure 25). The duodenal surface pH (7.14+0.12(12)) was 
not very different from control values (7.15+0.09(15)). 
When only acid secreting patients were considered, duodenal 
cap surface pH was lower in duodenal ulcer disease 
(6.96+0.14(7)) than in control patients (7.33+0.10(4)), 
although this could not be shown to be statistically 
significant. Of some interest was the fundal surface pH 
(2.36+0.27(10)) of atropinised acid secreting duodenal 
ulcer patients. This was more acid (p<0.02) than the pH of 
4.20+0.80(4) measured in atropinised acid secreting control 
patients. This data suggests that atropine exerts its 
effects more in the duodenum than it does in the fundus. 
The above data allows one to imply that the secretion of 
bicarbonate by the duodenum, when an ulcer is present, is 
partially controlled by cholinergic mechanisms which are 
blocked by atropine.
Finally, as well as gastric and duodenal ulcer 
patients, several patients with oesophagitis and patients 
with hiatus hernia were investigated. However, there were 
no unusual pH measurements found in these patient groups. 
Interested readers are referred to these results in 
Appendices 3 & 4.
In summary, similar to gastric ulcer disease, duodenal 
ulcer disease can be distinguished from the normal state by 
the presence of an increased mucosal surface pH within or 
near to the area of ulceration. This alkalinity becomes even 
more evident when acid is in the stomach.
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Figure 25. Duodenal cap surface pH of atropinised control and 
duodenal ulcer patients with (pH < 3) or without (pH > 3.0) acid 
in the fundus. Number of patients in parentheses.
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DISCOSSTOW
With the development of any new technique, various 
unforseen problems will arise, the majority of which are 
soluble. However, there will always be limitations to any 
system and it is important that these are recognised. It is 
the purpose of the following section to clarify certain 
assumptions which have been made and to discuss the merits 
and limitations of each system.
5 i) .Castro-duodenal measurements .at endoscopy
To measure gastrointestinal surface pH, existing 
clinical procedures have been adapted for the intended 
purpose. Apart from convenience, there are two other major 
benefits to measuring gastro-duodenal surface pH at 
endoscopy. Firstly, the position of the electrode can be 
determined accurately and the flexibility of the endoscope 
allows measurements to be made within virtually any area of 
the stomach or duodenum. In contrast, the position of free- 
floating electrodes within the stomach cannot be accurately 
determined or controlled. The second major advantage is 
that the existence of any mucosal disease can be examined 
at the same time as the experimental measurement is made. 
Therefore, patients do not need to undergo any more 
examinations than are necessary for clinical diagnosis.
In previous reports (70,71) of endoscopic pH 
measurement no mention was made about the practical 
difficulties which may be encountered. In neither report 
was reference made to the pH of the luminal contents. It is 
indeed quite difficult to obtain a steady recording of pH
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in the gastric lumen in regions other than the fundus. Only 
if gastric juice was present in relatively large quantities 
could this be achieved. Unless a fluid continuum existed 
between the pH electrode in the lumen and the buccal mucosa 
no stable pH values could be obtained. Were it possible to 
use a combined pH and reference electrode at endoscopy, 
luminal pH could be measured with greater reliability. With 
such a system the close proximity of the two electrodes to 
each other would ensure less fluctuation of the recording 
as interruption of fluid continuity would be less likely. 
This problem will not be resolved until a suitable 
electrode of sufficiently small diameter is designed for 
passage through the endoscope.
When the electrode was placed on the gastric and 
duodenal surface it was assumed that the value of pH 
recorded at this time was the pH of the mucosa. There are 
however, some distorting influences which must be 
considered. It cannot be said for certain that the 
electrode was in contact with the mucosa alone. The rounded 
tip of the electrode meant that a contribution to the 
recorded pH from luminal fluid impinging on the pH 
sensitive glass could not be discounted. Thus the recorded 
value would be a composite of mucosal and luminal pH. This 
luminal contribution to the recorded pH would be far less 
than that of conventional, large diameter glass pH 
electrodes floating free in the stomach or duodenum because 
of the smaller size of the electrode tip (1.4mm). However, 
even with the small glass electrode, the pH values for the 
mucosa cannot be without uncertainty. It must therefore be
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assumed that the recorded pH is that of the overlying mucus
layer and not that precisely at the epithelial cell 
surface.
From each region only two measurements of mucosal pH 
were made and these were averaged to give a mean value. 
Were it possible to 'map' the entire area diligently within 
the time available, the average pH might differ from the 
value obtained with the present procedure. In addition, the 
recorded values only represent the pH at the time of 
endoscopy. With this system it is not feasible to monitor 
mucosal pH over long periods of time. Without such a study, 
it cannot be known if the surface pH remains constant or 
varies with the amount of acid secreted or to what extent 
food or other substances may alter the mucosal pH. Patients 
were examined after an approximately 12 hour fast and 
usually in the early afternoon, all factors which would 
suggest that the gastric secretions were at basal levels. 
However, until a non-invasive means of measuring mucosal pH 
is devised it cannot be known what effect the mere presence 
of the endoscope will have on gastric and duodenal
secretions.
Despite these uncertainties, endoscopy as a means of 
delivering an electrode to the gastrointestinal mucosa is 
efficient, quick and provides minor discomfort to the 
patient. Its use is limited to the stomach and proximal 
duodenum so alternative systems must still be used for 
measuring small intestinal mucosal pH.
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5 ii) Thz measurement af small intestinal mucosal pH
The Crosby capsule-electrode assembly is a novel system 
for measuring small intestinal mucosal surface pH. 
Measurements can be obtained as an adjunct to jejunal 
biopsy without interfering with the clinical test. In 
return, the clinical test can be enhanced from the 
information provided by continuous pH monitoring. This is 
exemplified by pH changes signalling movement of the 
capsule from the stomach to the duodenum, dispensing with 
the need to X-ray the patient as frequently as is sometimes 
necessary when monitoring capsule movement. Subsequent 
capsule-electrode transit can only be determined by inter­
mittent fluoroscopy.
To improve the chances of contact between the 
electrode's pH sensitive surface and the tissue, the 
electrode tip was positioned almost perpendicularly to the 
mucosa. If the buccal reference electrode was momentarily 
removed from the mucosa, sharp deflections of the pH 
readings into the acid range could be produced. Such 
deflections were also seen when increased intestinal 
motility was induced in patients by administering 
Metaelopramide hydrochloride (Maxolon, Beecham; 10-20mg
i.v.). This would suggest that the electrode intermittently 
lost contact with the mucosa, severing coupling between 
reference and pH electrodes. Using this criterion, it was 
possible to tell when the electrode was not touching the 
mucosa. Even if some doubt remains about mucosal-electrode 
contact, the final jejunal pH reading is almost certainly 
representative of the mucosal pH. By drawing the mucosa
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into the capsule, the electrode, being close to the capsule 
apperture, must touch the tissue and register the pH.
In the jejunum, surface pH can be expressed with 
reference to villous height, villous to crypt cell ratios, 
enzyme activities and related measurements. Unfortunately 
it was not possible to examine the duodenal tissue to 
determine any correlations between the duodenal pH and 
histological or biochemical findings. An improvement of 
this system would be to use a multiple biopsy system which 
would excise tissue from several identifiable positions 
along the intestine during the same investigation.
A further uncertainty was knowing how long the 
electrode remained in any one position. If the capsule- 
electrode assembly moved through the intestine at a 
constant rate then it would be simple to identify changes 
in mucosal pH with respect to time and position. However, 
variations in intestinal motility do not allow such 
assumptions to be made and X—ray hazards do not permit 
continuous screening of the patient. A mercury-bag 
attachment may assist the movement of the assembly through 
the intestine at a more even rate.
In summary, the Crosby-capsule electrode measuring 
combination has, for the first time, allowed in vi,v Q 
measurements of human proximal small bowel surface pH to be 
made with minimal effort. As with any new technique there 
will always be improvements which can be made and some of 
those suggested here might make what is already a simple 
but highly effective procedure even more useful and
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reliable. The possibility of measuring mucosal surface pH 
in more distal regions of the intestine remains to be 
investigated although there is no reason why this should 
pose a problem.
5 iii)An assessment Q t  Plastic pfl electrode.
It was for use with this capsule-electrode system that 
a plastic pH electrode was developed. A large proportion of 
the project was devoted to overcoming various unforseen 
electrode development problems. One such problem was the 
water-tight seal between the internal filling solution and 
the outer screening of the cable. The present use of 
silicone rubber, varnish and PVC has eliminated the sealing 
problem.
Many electrodes were discarded because of air bubbles 
appearing in the internal filling solution during storage. 
These eventually rendered the electrode useless by breaking 
the fluid contact between the silver wire and ion-selective 
membrane. The bubbles were subsequently found to be the 
result of evaporation of water through the PVC. Whether 
evaporation occurred through the PVC tubing or the membrane 
is not clear but evaporation was evident within 24hrs. A 
simple answer to the problem was to store the electrodes in 
pH 7 Tris/HCl buffer when not in use. Water evaporation 
from the electrode never occurred during an experiment.
The functional characteristics of the two hydrogen ion 
ionophores have been studied. TDDA was selected as the ion 
exchanger for the plastic electrodes, rather than OCPH, 
because of its wider operative pH range and its higher
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cation selectivities. TDDA, a neutral ion-carrier, has 
consistently been shown to have better operating 
characteristics than charged ionophoresf whether 
incorporated in plastic (112) cast in plastic onto ion- 
selective field effect transistors (ISFETs) (126) or used 
in liquid membranes for microelectrodes (113).
The formula used in preparing the TDDA membrane 
solution was not based on the prescribed formulation (112) 
but this did not affect the response obtained with these 
electrodes. Indeed, the pH range, cation selectivity, 
response time, resistance and drift of these electrodes are 
comparable to previously published results (112). This does 
not necessarily mean that the composition of a membrane 
solution has no effect on electrode performance. Previously 
described plastic pH electrodes (112,126) have been 
constructed from powdered PVC with an appropriate 
plasticiser. While the choice of plasticiser appears not to 
affect the slope of the electrode response, it does cause 
variations in electrode drift (126). The amount of drift 
noticed with the intestinal pH electrodes when used in sit-U 
in this study was never excessive and could be corrected 
for, but it is interesting to note that the same degree of 
drift never occurred in buffer solutions. This would 
suggest that some constituent of intestinal fluid 
"interferes" with the electrode. Since PVC tubing was used 
in the construction of the electrode membranes the 
plasticiser was not known. However, by using powdered PVC 
and selecting an appropriate plasticiser, electrode drift 
in niin might be eliminated. This awaits further
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investigation.
TDDA plastic pH electrodes, with a lower limit of 
detection of pH 4, are not suitable for measuring gastric 
pH. A neutral hydrogen ion-selective carrier, which 
functions in the acid range (pH 1—4), has recently been 
developed (127). However, although useful for measuring 
gastric pH, it does not satisfy the requirement for a 
plastic pH electrode which responds over the entire pH 
range (pH 0-14). Until a suitable ion exchange carrier is 
developed, plastic pH electrodes will continue to be 
regarded with scepticism by researchers accustomed to 
working with glass electrodes.
The potential design of plastic pH electrodes will be 
determined by the purpose for which they are desired. 
Likewise, the electrode design described here could be used 
for measuring other ions of interest. By substituting the 
ion-exchanger with an appropriate alternative, intestinal 
measurements of potassium, sodium or virtually any other 
ion could be made. The electrodes could be used in 
conjunction with the Crosby capsule for intestinal mucosal 
ion measurements or, allowed to float free in the gastro­
intestinal lumen, these electrodes could provide ion 
measurements of instilled solutions. Such studies would be 
useful for monitoring ion movements in secretory diarrhoea 
qjt following the absorption of drugs sg. methadone 
absorption (106), where suitable ligands exist.
In conclusion, plastic pH electrodes can be used 
successfully for intestinal pH measurements and they may
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soon be available for gastric pH measurements. With 
responses similar to glass electrodes they are an adequate 
substitute, an important point when one considers that they 
can be produced for a fraction of the cost of glass 
gastrointestinal pH electrodes. Finally, plastic electrodes 
can be constructed for measuring most ions of interest and, 
because of the versatile ways in which plastic can be used, 
they may be adapted for most purposes.
5 iv) Gastrointestinal disease and mucosal pfl
The pH results obtained in this present study using the 
devised measuring systems have shown that there are changes 
in mucosal pH when gastrointestinal disease is present. It 
is the purpose of the following section to discuss these 
results.
From the results of the two separate clinical studies 
performed as part of this project, a pH profile of the 
mucosa of the proximal gastrointestinal tract can be 
described. Essentially, the mucosal pH in the stomach of 
normal patients is acid, becomes neutral in the duodenum, 
and gradually acidifies towards the jejunum. This is a 
simplified view, particularly in the stomach where the 
mucosal pH will vary with the pH of the gastric juice. The 
pH profile and the gastric mucosa response to gastric juice 
is altered when the tissue is damaged. There were markedly 
abnormal mucosal pH changes in the three major gastro­
intestinal diseases investigated: coeliac disease, gastric
ulcer and duodenal ulcer. In each case the disease is
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characterised by an increase in the mucosal pH of the 
affected area. In the jejunum, the pH of the normally 
acidic mucosa approaches neutrality in coeliac disease. In 
gastric ulcer disease, the pH of the antrum rises to 
neutrality, regardless of the gastric juice pH. Finally, 
duodenal ulcer disease is associated with a normally 
neutral duodenal mucosa becoming alkaline. Alkalinity is 
the common factor in all cases.
5 iv) a) Mucosal pB of the. small intestine
A jejunal mucosal pH of 5.9 measured in control 
patients was remarkably similar to values recorded from 
human biopsy tissue (73,74). This value probably reflects a 
mixture of villous tip acidity and crypt cell neutral or 
alkaline fluid secretion. Using microelectrodes, Lucas et 
al (128) have measured a microclimate pH of 6.3 in rat 
proximal jejunum In vitro. pH 6.3 was also the value 
obtained in rat In vivo studies using mini glass electrodes 
(tip diameter = 1.5mm) (129). However, in each case, the 
exact location of the electrode tip in relation to the 
jejunal villi was unknown. In a recent paper (130) a mean 
pH of 6.65, the lowest recorded in these experiments, has 
been measured between 10 and 50um below the villous tip 
with antimony microelectrodes. Measurements in the crypts
gave alkaline values.
Antimony electrodes are sensitive to oxygen tension 
(131) so results obtained with these electrodes may be 
suspect. A different pH profile from that measured with 
antimony electrodes has been measured using liquid ion
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exchanger microelectrodes (H. Daniel, private communication 
1986). With the liquid ion exchanger electrodes the lowest 
pH value recorded at the villous tips was pH 6.2 with no 
increase in pH as the electrode moved down into the crypt 
cell region. The acid region of the villi corresponds to a 
position adjacent to cells thought to be morphologically 
best adapted for digestion and absorption (132). As yet, it 
has not been possible to measure values as low as pH 5.3 
which was proposed, on the basis of drug absorption studies 
(133), as the real pH at the epithelial cell surface. In 
summary, the present pH values obtained at biopsy agree 
with estimates in rat proximal jejunum.
The mechanism by which the normal jejunum acidifies the 
mucosa is not fully understood, although there are some 
indications as to how this may occur. The mechanism of 
acidification of the luminal bathing solution has been 
studied (134,135) using the everted sac technique (136). 
Acidification can occur in the absence of glucose in the 
incubating medium but is increased at glucose 
concentrations greater than ImM. However, acidification is 
not a consequence of the active transport of hexoses since 
galactose and 3-0-methylglucose, although actively 
transported, do not increase acidification. Increased 
acidification results from the absorption of metabolisable 
sugars such as glucose and fructose, which are actively 
transported, and mannose, which is not. ATP, applied 
exogenously to the jejunal mucosa increases acidification 
which is abolished by aminophylline, a phosphodiesterase 
inhibitor. These observations (134) have led to the
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conclusion that acidification results from the hydrolysis 
of ATP and depends on aerobic metabolism of sugars.
Acidification of the jejunal mucosa may occur through 
hydrogen ion secretion or bicarbonate absorption. A rise in 
pC(>2 of bicarbonate solutions instilled! into the jejunum 
(88,137,13 8) seems to favour hydrogen ion secretion rather 
than bicarbonate absorption per se. As well as mediating 
bicarbonate absorption, hydrogen ion secretion enhances 
sodium absorption through a sodium-hydrogen exchange 
mechanism (137,138,139) thought to exist in the jejunal 
mucosa (140). However, measurements of the serosally 
directed sodium flux (135) do not change when acidification 
is inhibited by aminophylline. This suggests that sodi um- 
hydrogen exchange may not be the only mechanism in the 
acidification process.
Instead, a hydrogen-potassium exchange mechanism which 
could account for two-thirds of acidification is postulated 
(135). The serosally directed potassium flux in the jejunum 
is the same order of magnitude as the mucosally directed 
hydrogen flux and both oubain and aminophylline can reduce 
potassium uptake to zero, paralleling their effect on 
acidification. Potassium uptake by jejunal mucosa is 
increased in the presence of metabolisable sugars (X41K 
This does not imply that potassium uptake is coupled to 
active transport of sugars since the uptake of 
unmetabolisable actively transported sugars reduce 
potassium absorption (141). Similarly, hydrogen ion 
secretion is unaffected by the active transport of 
unmetabolisable hexoses but is increased when metabolisable
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sugars are transported (134). This metabolic dependency of 
potassium absorption and hydrogen ion secretion lends 
further support to the existence of a hydrogen-potassium 
exchange mechanism, probably situated in the apical 
membrane of epithelial cells.
An alternative transport mechanism for hydrogen ions 
might occur through the translocation of metabolically 
produced lactic acid (130). A mucosally directed diffusion 
of lactic acid would be followed by the dissociation of 
lactic acid to lactate and hydrogen ions in the acid micro­
climate. Lactate would then facilitate sodium absorption 
through an electroneutral lactate-Na+ cotransport system.
It has been suggested that the acid microclimate is not 
due to hydrogen ion secretion but to the mucus layer (142). 
It is postulated that mucus is an ampholyte which allows 
hydrogen ions to enter down their concentration gradient 
when the bulk solution is acid. When the perfusing 
solution is alkaline, it is suggested that negatively 
charged mucus retains hydrogen ions within the mucus layer. 
Thus an acid microclimate can be maintained. Removal of the 
acidic mucosubstance by shearing eliminates the acid micro- 
climate. The subsequent failure of glucose at 
concentrations upto 14mM to reproduce this region of 
acidity is given as evidence that glucose stimulated 
hydrogen ion secretion is insufficient to maintain an 
acidic microclimate. However, the authors have yet to 
provide corroborative evidence to explain various factors 
like sodium dependency of acidification and the effects on
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acidification of selective inhibitors of carrier 
mechanisms.
In conclusion, acidification of the jejunal mucosa 
could potentially occur through a number of transport 
mechanisms and any one or more may ultimately be 
responsible. Future investigations may eventually provide a 
definitive answer.
Hydrogen ion secretion is assumed to occur from the 
absorptive villous tips of the jejunum, corresponding to 
the low pH recorded close to this region (130). Removal of 
the villous tips, as occurs in coeliac disease, would 
prevent hydrogen ion secretion and a neutral or alkaline 
mucosal pH would be expected. The near neutral jejunal 
mucosal pH measured jja vivo in coeliac disease confirms 
previous in vitro findings (73,7 4). The highest pH readings 
were obtained from untreated patients with villous atrophy, 
but treated patients with a structurally normal jejunal 
mucosa were also shown to have an elevated surface pH. It 
is possible that the apparent increase in jejunal surface 
pH is the result of two, not necessarily exclusive, 
mechanisms.
Firstly, coeliac disease is characterised by a flat 
avillous mucosa with crypt cell hyperplasia.. As well as the 
loss of acid-secreting absorptive cells, there is reported 
to be an approximately three fold increase in the number of 
crypt cells (143). It is still unknown to what extent crypt 
cells contribute to intestinal secretion but areas 
containing crypt cells but not villi, such as the colon, do
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not acidify their contents (144). Whether the crypt cells 
secrete bicarbonate is as yet unknown but intestinal 
secretion in coeliac disease is associated with an increase 
in tissue prostaglandin E2 (145) which stimulates 
bicarbonate secretion in the human duodenum (62). Thus, 
fluid secreted onto the surface of the tissue by crypt 
cells is likely to be neutral or alkaline and may account 
for the observed mucosal pH in coeliac disease.
The apparent increase in jejunal surface pH in coeliac 
disease may also be the result of an increase in tissue 
permeability. Increased tissue permeability has been 
measured in coeliac patients using the cellobiose/mannitol 
test (146,147). The exudation of fluid through the 
paracellular pathways would contribute to the crypt cell 
secretion and help maintain a neutral surface pH. An 
increase in intestinal permeability is often present in 
treated coeliac patients with structurally normal jejunal 
mucosa (146), as determined by routine microscopy. However, 
recent computerised morphometry studies (148) show that 
subtle changes in an apparently normal looking biopsy are 
associated with an increase in cellobiose/mannitol 
absorption. This may well explain the persistently elevated 
surface pH measured in treated coeliac patients with normal 
jejunal mucosa.
Jejunal biopsy disaccharidase activity was measured for 
each patient and a correlation was found between lactase, 
maltase and sucrase activities and mucosal pH. A similar 
correlation between in vitro jejunal mucosal pH and lactase 
activity has been noted (149). An important aspect of
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measuring disaccharidase activities by the method of 
Dahlqvist (118) is that the enzyme-substrate incubation 
occurs at pH 6, which is the optimum pH value for 
disaccharidase activity in tissue homogenates (150). This 
is appropriate for normal jejunal tissue. However, the 
measured activity of enzymes obtained from patients with a 
high surface pH does not necessarily reflect the true 
activity occurring at the tissue microclimate pH. Under 
these circumstances, the true activity may well be higher 
or lower than the measured activity. In retrospect, the 
optimum pH for disaccharidase activity should have 
suggested that the pH at the mucosa of healthy individuals 
would be approximately pH 6.
In conclusion, while other people have measured jejunal 
surface pH in animals in vitro and in Vi-Vn and in man in 
vitro since Lucas first applied electrodes to rat jejunum 
(128), this is the first instance where jejunal mucosal pH 
has been measured in humans in yi^n« Measuring jejunal 
surface pH in humans has confirmed the findings of the in 
vitro human studies and shows that an acid microclimate is 
not an in vitro artifact. The similarity between human and 
rat jejunal mucosal pH means that the rat is a useful model 
for studying the effect of surface pH on weak electrolyte 
absorption and can be used for studying drug pharmaco­
kinetics.
5iv) b) Peptic .ulceration .and mucosal pH
It is proposed in the cytoprotection hypothesis (50) 
that a neutral zone of mucus and bicarbonate exists at the
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mucosal surface of the stomach and duodenum. Mucosal damage 
is thought to be the result of the failure of this zone to 
inhibit the action of acid and pepsin on the mucosa.
Bicarbonate secretion has been measured in gastric and 
d u o d e n a l  tissue of several animal species 
(46,47,48,49,50,51). Several species and regional 
differences have been noted but there are some 
characteristics which appear common to all. Both gastric 
and duodenal bicarbonate secretion are dependent on 
metabolism since transport is abolished by metabolic 
inhibitors (59,60). Gastric secretion of bicarbonate 
possibly occurs through an electroneutral HC03-C1- exchange 
at the luminal membrane of surface epithelial cells (151). 
However, duodenal transport seems more complex for evidence 
exists for both an electroneutral HCO3-CI” exchange (151) 
and an electrogenic transport of HCO3 (60,151).
Instilled acid is a strong stimulus of bicarbonate 
secretion in the duodenum (61,62,66). The mechanism by 
which acid stimulates bicarbonate production may occur 
through several second messenger systems which have been 
implicated in bicarbonate secretion. Cholecystokinin (CCK), 
pancreatic glucagon and gastric inhibitory polypeptide 
(GIP) stimulate duodenal bicarbonate secretion but secretin 
and vasoactive intestinal polypeptide (VIP) do not (151). 
This effect of VIP on amphibian duodenum is in contrast to 
the increase in bicarbonate secretion from rat duodenum 
observed after intravenous infusion of VIP (152). This 
difference is likely due to the absence of Brunner's glands 
in the amphibian duodenum. The effect of CCK on gastric
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mucosal bicarbonate secretion may be masked by a 
concomitant increase in hydrogen ion secretion (151). Other 
hormones investigated for their effect on gastric 
bicarbonate secretion include glucagon, which stimulates, 
and GIP, which inhibits bicarbonate production (151).
There is much evidence to suggest that formation of 
prostaglandins is important in the gastr©-duodenal defence. 
Prostaglandin E2 (PGE2) and prostaglandin F2 (PGF2) are the 
two most prevalent prostaglandins isolated from human 
biopsy homogenates (153). Exogenous PGF2 and 16,16-dimethyl 
PGE2, a synthetic analogue of PGE2, stimulate alkaline 
secretion in the isolated amphibian gastric mucosa (49) 
while 16,16-dimethyl PGE2 causes a dose-dependent rise of 
luminal alkalinisation of bullfrog duodenum (59). FGE2 also 
increases duodenal bicarbonate secretion in cats, rats and 
dogs, but not in guinea pigs or rabbits (61). Inhibitors of 
prostaglandin synthesis reduce or inhibit bicarbonate 
secretion (61,151,154), while activators of endogenous 
prostaglandin formation stimulate secretion (155). 
Prostaglandins are also known to stimulate intestinal fluid 
and ion secretion in humans (156).
Finally, neural control of bicarbonate secretion has 
only recently been examined, although vagal stimulation has 
been known to cause duodenal alkali secretion for many 
years (124). Stimulation of cat vagal fibres causes an 
increase in gastric bicarbonate secretion (125) and 
electrical field stimulation of amphibian duodenal 
bicarbonate secretion is reduced by atropine, indicating
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the existence of muscarinic receptor control of secretion
(157). This muscarinic receptor control of bicarbonate 
secretion is perhaps another example of species differences 
since the muscurinic agonist carbachol has only a slight 
stimulatory effect on rat duodenal bicarbonate secretion
(158). The adrenergic neural system also appears to be 
involved since alpha^-adrenoceptor agonists promote 
duodenal bicarbonate secretion (159). These observations on 
the control of bicarbonate secretion are summarised in 
Figure 26.
All this evidence favours bicarbonate secretion into 
the lumen by the gastro-duodenal mucosa but does not prove 
that a "mucus-bicarbonate" barrier exists at the mucosal 
surface. To substantiate this hypothesis, a near neutral pH 
should be measurable at the mucosal surface under normal 
conditions and conversely, when the cytoprotection fails to 
operate, an acidic mucosal pH would be expected. Several 
investigations of gastro-duodenal mucosal surface pH 
(64,65,66 ,160) have indeed shown that a neutral pH can be 
measured. As yet, this has not been confirmed in humans in 
vivo and nothing is known about the effects of ulceration 
on the "mucus-bicarbonate" barrier if this indeed exists in 
humans. From the results of this project, some very 
interesting observations can be made.
In control patients, a near neutral mucosal pH was 
measured from the fundus to the duodenum, but only when the 
fundal luminal fluid was higher than pH 3. This neutral pH 
could not be maintained in the stomach when the mean fundal 
lumen pH was 1.85. A similar observation in humans has
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recently been reported (69). in contrast, the results from 
this project reveal that peptic ulceration is associated 
with an increased surface pH which exists despite the 
presence of high concentrations of acid in the stomach. In 
both gastric and duodenal ulceration, the mucosa of the 
affected area was more alkaline than that in corresponding 
areas of control patients. The alkalinity was found to 
increase with the severity of the disease and when the 
fundal lumen pH was low.
There are two notable points from this data. Firstly, 
the neutral surface pH in normal patients cannot withstand 
acid and secondly, in ulcer patients, a more alkaline 
surface pH exists. The first point is perhaps not so 
surprising after closer examination of published data 
supporting the evidence for a neutral microclimate.
Previous studies of the pH gradient across the gastric 
mucus layer in rat in vivo (64) and human in jzitJLQ (65) 
have indicated that a near neutral zone can be measured. 
Interestingly, this zone cannot withstand acid at a 
concentration of 40mM (pH 1.4). In another study of rat 
fundus in vitro (160), even acid at 20mM was sufficient to 
abolish the pH gradient.
Similarly, a pH-gradient at the luminal surface of the 
rat duodenum in vivc does exist when the luminal pH is as 
low as pH 2 (66) although this is dissipated when the acid 
concentration perfusing the tissue is increased to 50mM
(160). An interesting point to note is the fact that a pH- 
gradient cannot be demonstrated in rat duodenum when an
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alkaline perfusate is used (160). (The actual findings are 
not reported). Consequently, a neutral microclimate may 
only exist if bicarbonate secretion is stimulated by acid 
perfusates. If a pH 7.4 perfusate is alkalinised, as has 
been reported (61), one would expect to find a mucosal pH 
the same as or more alkaline than the perfusate pH. Until 
this is demonstrated, the existence of net basal 
bicarbonate secretion must be regarded with some 
scepticism.
The concentration of acid necessary for abolishing the 
duodenal pH-gradient is higher than is necessary for the 
same effect on gastric mucosa but then the duodenal mucosa 
of several animal species produces bicarbonate at a much 
higher rate than the whole of the gastric mucosa (151). 
Consequently, acidification of the juxtamucosal layer when 
the lumen pH is low may be the result of a breakdown of the 
"mucus-bicarbonate" barrier. The fact that the present data 
shows that this occurs quite readily in normal patients 
suggests that it need not be pathological as is often 
thought.
The second interesting fact to emerge from this study 
was the appearance of a more alkaline surface pH in ulcer 
patients which was unaffected by gastric acid. The failure 
of cytoprotection and the development of an ulcer does not 
automatically imply that an acid surface pH should be 
detected in ulcer patients. After all, pH was measured once 
ulceration had occurred, that is, once the damage had been
done.
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An alkaline surface pH in peptic ulceration is likely 
to be the result of tissue inflammation. A more definitive 
explanation cannot be derived from this investigation but 
it is possible to speculate on potential mechanisms. 
Alkalinity may simply be due to an increase in plasma 
leakage of bicarbonate. Certainly, large volumes of fluid 
are secreted by the gastric mucosa when tissue permeability 
is increased by damaging substances such as salicylic acid
(161). Alternatively, the local release of prostaglandins 
stimulated by tissue damage will promote bicarbonate 
secretion. Increased duodenal prostaglandin activity has 
indeed been measured in duodenal ulcer patients (162) and 
increased levels of PGE2 have been found in patients with 
gastritis (163). There may even be an increased cholinergic 
stimulation of bicarbonate since, in this study, an 
alkaline surface pH could no longer be measured in gastric 
and duodenal ulcer patients when atropine was administered 
before endoscopy.
In summary, this study has shown that a neutral mucosal 
surface pH exists in the human stomach and duodenum. It has 
also demonstrated a less well appreciated fact that acid 
can significantly reduce the surface pH in normal patients. 
Finally, contrary to popular belief, ulcer patients have a 
significantly more alkaline mucosal pH which is more 
resistant to acid. This alkaline surface pH is likely to 
result from tissue inflammation.
It is difficult to reconcile the hypothesis of a 
neutral surface pH, which can withstand gastric acid, with
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what is known about the physiology of inhibition of acid 
secretion, gastric emptying and several other related 
topics. However, the findings of this study fit well with 
the known physiology of the gastrointestinal tract and the 
purpose of the following section is to elaborate on this 
point.
5 v) Mucosal sucfafifi pH .and gastrointestinal physiology.
Events occurring at the gastrointestinal mucosa have a 
direct bearing on the regulatory feedback mechanisms which 
control absorption, secretion and motility. These feedback 
mechanisms occur through both neural and hormonal 
transmission. Receptors in the duodenal mucosa, activated 
by acid, are implicated in the inhibition of acid secretion 
via a neural pathway (37), possibly consisting of vagal 
afferents responsive to acid stimulation of the duodenal 
mucosa (38). Similarly, duodenal regulation of gastric 
emptying is mediated through either a neural or a hormonal 
feedback system activated by acid in the proximal duodenum 
(32). Inhibition of gastrin release by acidifying the 
antrum (164) is a hormonal mechanism for inhibiting acid 
secretion and similarly, pancreatic bicarbonate secretion 
is stimulated by duodenal acid infusion (165) mediated by 
the acid induced release of secretin (45). Consequently, 
there is much evidence to suggest that acid is intimately 
involved in regulating these normal physiological
functions.
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To activate these feedback mechanisms, acid is required 
in relatively high concentrations. For instance, gastrin 
release is only inhibited when the antral pH is less than 
pH 2.5 (164). Likewise, pancreatic bicarbonate secretion is 
maximally stimulated when the duodenal pH falls below pH 3 
(45). If, however, the present interpretation of the 
cytoprotection hypothesis is correct, how these control 
mechanisms can operate becomes a mystery. By maintaining 
the mucosal surface pH at neutrality, as proposed in the 
cytoprotection hypothesis, acidity regulated feedback 
mechanisms will not be activated. The fact that they are 
activated proves that the cytoprotection hypothesis is 
essentially a biochemical model applied to a clinical 
problem and has no bearing on the physiology of the system. 
This is not to say that cytoprotection does not play an 
important role in protecting the mucosa from acid damage. 
Unfortunately, investigations of cytoprotection have tended 
to highlight its protective elements and have largely 
ignored some rather important data, perhaps because it does 
not fit with the current concept of mucosal protection.
It has been shown in this thesis and in published data 
(66,160) that a low luminal pH is sufficient to abolish an 
otherwise neutral mucosal surface pH. In all cases, the 
luminal pH was below pH 2 and this corresponds well with 
the pH required to activate the inhibitory mechanisms 
outlined above. Interpreting this data in a physiological 
context allows one to suggest the following.
Under conditions of basal acid secretion, a neutral
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mucosal surface pH is maintained and protects the mucosa 
from digestion by acid and pepsin. However, when the 
intraluminal acid reaches a particularly high 
concentration, the 'mucus-bicarbonate1 layer is 
insufficient to buffer the acid. Acid impinging on the 
mucosa can then stimulate inhibitory feedback control 
mechanisms, indicating an overloading of the system. 
Subsequent inhibition of acid and pepsin secretion, gastric 
emptying and stimulation of pancreatic bicarbonate 
secretion, all contribute to reducing the acid load. Thus, 
under this system, an equilibrium between aggressive and 
protective factors can be re-established.
In contrast, to assume that a neutral surface pH can be 
maintained is illogical. This would ultimately lead to 
unregulated increases in acid secretion and gastric 
emptying. It is highly unlikely that the mucosal protective 
mechanisms could withstand such an increase in acid load 
and the ‘mucus-bicarbonate' barrier would collapse. This 
collapse could be detected by measuring an acid surface pH 
when the gastric contents were acidic; this is exactly what 
has been found in this study.
To speculate on the cause of peptic ulceration is 
beyond the scope of this thesis but the observations made 
in this project may explain several anomalies associated 
with the disease. Unlike control patients, peptic ulcer 
patients maintained a significantly alkaline mucosal 
surface pH despite the presence of an acidic fundal lumen. 
From the preceeding discussion on the relationship between 
mucosal surface pH and physiological events, an alkaline
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surface pH is undesirable in the presence of a highly 
acidic bathing medium.
Increased gastric acid secretion and gastric emptying 
in duodenal ulcer disease are compatible with a failure of 
acid to inhibit these responses. Similarly, reduced levels 
of plasma secretin, which have been measured in duodenal 
ulcer patients (42), can be explained by the failure of 
acid to stimulate secretin release from the duodenum. A 
less than normal plasma secretin concentration will reduce 
pancreatic bicarbonate secretion and have less of an 
inhibitory effect on acid seer et ion. Acid is also 
responsible for the release of 5-hydroxytryptamine (5-HT) 
from the duodenal mucosa (166) and 5-HT is an inhibitor of 
gastric acid secretion (167). Once again an alkaline 
surface pH would prevent the release of 5-HT and acid 
secretion will continue unabated. Finally, an increase in 
gastric emptying in duodenal ulcer disease may also be 
attributed to an alkaline surface pH in the duodenum. 
Perfusion of the dog duodenum with alkaline solutions 
significantly increases motility in denervated fundic 
pouches (168). This suggests that alkalinity either 
inhibits the release of an inhibitory hormone or 
conversely, promotes gastric motility through the release 
of a stimulatory hormone.
In addition to the possible effects of alkalinisation 
on hormonal control mechanisms, neural inhibition of acid 
secretion and gastric emptying may also be reduced. As well 
as vagal afferent fibres originating from mucosal
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chemoreceptors sensitive to acid, vagal afferent fibres 
responsive to instilled alkali have been isolated in the 
cat stomach (35,38) and duodenum (38). However, the 
function of alkali-sensitive receptors is unknown. The 
possibility that these receptors may be stimulated by an 
alkaline mucosal surface pH suggests a role for them in the 
pathogenesis of peptic ulceration.
Consequently, by maintaining an alkaline surface pH in 
peptic ulcer disease, acid in the antrum and duodenum would 
fail to inhibit subsequent gastric acid secretion and 
gastric emptying and also result in reduced pancreatic 
bicarbonate output. It can be implied therefore, that 
alkalinity in peptic ulcer disease drives the system. That 
is, the mucosal tissue is faced with an ever-increasing 
acid load which can only lead to further tissue damage and, 
by implication, increased tissue alkalinity. This is 
consistent with the view that peptic ulceration is often 
associated with increased acid output. It also complements 
the suggestion that an increase in acid secretion does not 
precede but is the result of ulceration (7).
In conclusion, the cytoprotection hypothesis, as it 
stands, is not compatible with the existence of regulatory 
feedback systems which are known to exist. In contrast, the 
results from this study show that acid could potentially 
exert its inhibitory effects by dissipating the near 
neutral microclimate. Finally/ an increase in mucosal pH in 
peptic ulcer patients may explain factors such as increased 
acid secretion and gastric emptying measured in these 
patients. Therefore, while bicarbonate secretion may be
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important in protecting the mucosa from acid and pepsin, 
inappropriate bicarbonate secretion is likely to be 
pathological.
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APPENDIX 1
FPBMPLAE EDE B.PFFER SOLUTIONS
BICARBONATE BUFFER* pH 9; 0.1M.
84.54ml, 1M sodium bicarbonate + 7.74ml, 1M sodium 
hydroxide; made upto 1L.
CITRATE BUFFER pH 5; 0.1M.
21.01g citric acid + 200ml, IN sodium hydroxide; 
made upto 1L.
PHOSPHATE BUFFER pH 5; 0.1M.
99.2ml potassium dihydrogen orthophosphate (KH2PO4)
(0.907g/100ml)
0.8ml disodium hydrogen orthophosphate (Na2HP04)
{1,187g/100ml)
PHTHALATE BUFFER pH 4; 0.1M.
50ml, (20.42g/l) potassium hydrogen phthalate; made 
upto 1L.
TRIS BUFFER* pH 7; 0.1M.
100ml, 1M hydrochloric acid + 107.2ml, 1M Tris- 
(hydroxymethyl)aminomethane; made upto 1L.
References:
Wissenschatliche Tabellen. Eds. Diem, K. and Lentner, 
C.; Ciba-Geigy Limited, Basle 1968: 27 4-276. 
*Biochemists Handbook. Ed. Long, C.; E. & F.N. Spon 
Limited, London 1971.
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APPENDIX 2
AGES £E PATIENTS EXAMINED AT ENDOSCOPY
CLINICAL GROUP 
Normal
Duodenal Ulcer 
Gastric Ulcer 
Duodenitis 
Gastritis 
Oesophagitis 
Hiatus Hernia
AGE LYEARS? mean+sem)
EO..ATRQPINE
51.5*3.5
41.5*4.2
48.6*3.6
38.9+3.3+
56.2*5.8
53.2+4.1
52.0+9.2
ATROPINE
32.5+4.1
47.6*2.8
55.0*3.3
37.3*3.7
61.3*2.6
**
**
59.1+7.1 * *
Pernicious Anaemia 52.5+3.0
+ p<0.05; * p<0.01; ** p<0.001
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APPENDIX 3
UPPER GASTROINTESTINAL SURFACE jpg MEASUREMENTS
(Mean+SEM)
OESOPHAGUSGROUP
Normal
Duodenal Ulcer
Gastric Ulcer
Duodenitis
Gastritis
Oesophagitis
Hiatus Hernia
Pernicious
Anaemia
5.09+0.37(24) 
4.74*0.48(19) 
5.61*0.34(21) 
4.63*0.46(12) 
4.60+0.86(6) 
4.38+0.54(16) 
4.15*1.12(4) 
7.24+0.31(5)**
p<0.01;
FUNDUS
4.86*0.46(24) 
3.73*0.47(21) 
4.70*0.44(21) 
4.24*0.64(13) 
4.85+1.22(6) 
3.67*0.54(16) 
3.81+1.48(4) 
6.19*0.71(5)
** pCO.001
ANTRUM
5.63*0.44(24) 
6.46+0.34(21) 
6.96*0.15(21)* 
5.20*0.57(14) 
6.68+0.30(6) 
4.58+0.52(16) 
5.41+0.96(4) 
7.39*0.18(5)**
JQPEER GASTROINTESTINAL .SHBF.ACE m  MEASUREMENTS
(Mean+SEM)
GRQUE
Normal
Duodenal Ulcer
Gastric Ulcer
Duodenitis
Gastritis
Oesophagitis
Hiatus Hernia
Pernicious
Anaemia
PYLORUS
6.99+0.35(21)
7.16+0.20(19)
7.11+0.18(19)
7.28+0.14(11)
7.13+0.28(6)
6.20+0.56(16)
7.82+0.14(5)
7.43+0.24(5)
DUODENUM
i.CAP)
7.05+0.16(23)
7.26+0.08(20)
7.16+0.08(19)
7.21+0.08(14)
7.13+0.08(6)
7.13+0.16(16)
7.17*0.05(5)
7.22+0.12(5)
DUODENUM
1L.QQE).
7.09+0.09(22)
7.20+0.15(17)*
7.06+0.07(19)
7.08+0.12(12)
7.00+0.11(4)
7.14+0.10(13)
7.06+0.08(5)
7.15+0.07(5)
•ft
p<0.01? Chi-squared test
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PPPBR GftSTRQIMTESTIHftL LPHIHflL CH MEASUREMENTS
* *
(Mean+SEM)
GROUP OESOPHAGUS FUNDDS ANTRDM
Normal 4.47+0.43(24) 3.52+0.48(24) 5.81+0.55(24)
Duodenal Ulcer 3.81+0.51(20) 2.99+0.44(22) 7.68+0.26(20)
Gastric Ulcer 4.36+0.54(21) 3.62+0.52(21) 6.95+0.43(21)
Duodenitis 4.41+0.6 5(12) 2.62+0.48(12) 4.89+0.68(14)
Gastritis 3.67+1.07(6) 2.56+1.03(6) 7.66+0.60(6)*
Oesophagitis 3.53+0.59(16) 2.51+0.55(16) 4.24+0.66(16)
Hiatus Hernia 3.48+1.48(4) 2.99+1.49(4) 6.31^1.47(4)
Pernicious 7.24*0.31(5) ***7.08+0.16(5) ***8.20+0.14(5) ***
Anaemia
* p<0.05; ** p<0.01; *** p<0.001
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UPPER GASTRQIHTESTIHAL LUMINAL £Q MEASUREMENTS
(Mean+SEM)
EYLQBUSGROUP
Normal
Duodenal Ulcer
Gastric Ulcer
Duodenitis
Gastritis
Oesophagitis
Hiatus Hernia
Pernicious
Anaemia
7.12+0.45(21)
7.68*0.26(20)
7.35+0.35(19)
7.23+0.60(11)
7.53+0.49(6)
6.61+0.58(16)
8.20+0.08(4)
8.17+0.14(5)
DUODENUM
-LCAEl
7.65+0.11(23)
7.45+0.23(21)
7.60+0.09(19)
7.68+0.11(14)
6.62+0.99(6)
7.41+0.34(16)
7.54+0.24(5)
7.92+0.12(5)
DUODENUM 
f LOOP)
7.56+0.08(22)
7.58+0.16(18)
7.46+0.09(19)
7.49+0.17(12)
7.43+0.18(4)
7.68+0.11(13)
7.45+0.10(5)
7.79+0.17(5)
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APPENDIX £
GEEEB GASTROINTESTINAL SURFACE pH MEASUREMENTS 
£E PATIENTS flllfl ATROPINE PRE-MEDICATTON
(mean+sem)
GROUP OESOPHAGUS FUNDUS ANTRUM
Normal 5.64+0.32(14) 4.62+0.44(15) 6.43+0.35(16)
Duodenal Ulcer 4.52+0.36(17)* 3.35+0.45(17) 5.56*0.41(17)
Gastric Ulcer 5.95+0.43(10) 5.12+0.72(10) 6.72+0.38(10)
Duodenitis 4.09+0.52(12) 4.04+0.53(15) 5.79+0.48(15)
Gastritis 6.56+0.51(7) 6.06+0.95(6) 7.29+0.26(7)
Hiatus Hernia 6.19+0.45(7) 6.11+0.85(6) 5.83+0.73(7)
* p<0.05? ** p<0.02
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UPPER GASTROINTESTINAL .SURFACE MEASUREMENTS
£E PATIENTS WITH ATROPINE PRE-MEDICATION
GROUP
Normal
Duodenal Ulcer 
Gastric Ulcer 
Duodenitis 
Gastritis 
Hiatus Hernia
(mean+sem)
PYLORUS
7.34+0.11(14)
7.12+0.22(13)
7.86*0.16(9)**
7.34+0.16(12)
7.35*0.19(6)
6.72*0.27(7)*
p<0.05; p<0.02
DUODENUM)CAP)
7.15+0.09(15)
7.14+0.12(12)
6.98*0.11(10)
7.05*0.15(16)
7.33*0.22(6)
6.89*0.11(7)
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JIEEEB GASTROINTESTINAL LUMINAL fiH MEASOREMENTS
Q£ PATIENTS KITH ATROPINE PRE-MEDICATION
GRODP
Normal
Duodenal Ulcer 
Gastric Ulcer 
Duodenitis 
Gastritis 
Hiatus Hernia
OESOPHAGUS FUNDUS ANTRUM
5.3 8+0.34(14) 4.37+0.50(15) 6.93+0.42(16)
4.12*0.46(17)* 3.06+0.46(17) 5.84+0.51(17)
5.62+0.75(10) 4.93+0.83(10) 7.45+0.47(10)
3.22+0.55(12)**2.47+0.46(15)**6.41+0.51(15) 
6.54+0.65 (7) 5.98+1.01(6) 7.70*0.45(7)
6.05+0.69(7) 5.65+1.08(6) 6.37*0.86(7)
* p<0.05; ** p<0.01
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